false Q1 --12-31 0001679817 P5Y P5Y P5Y P5Y 0001679817 2024-01-01 2024-03-31 0001679817 2024-05-14 0001679817 2024-03-31 0001679817 2023-12-31 0001679817 us-gaap:SeriesDPreferredStockMember 2024-03-31 0001679817 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001679817 us-gaap:SeriesEPreferredStockMember 2024-03-31 0001679817 us-gaap:SeriesEPreferredStockMember 2023-12-31 0001679817 us-gaap:SeriesCPreferredStockMember 2024-03-31 0001679817 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001679817 2023-01-01 2023-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2023-12-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-12-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-12-31 0001679817 us-gaap:CommonStockMember 2023-12-31 0001679817 us-gaap:TreasuryStockCommonMember 2023-12-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001679817 us-gaap:RetainedEarningsMember 2023-12-31 0001679817 us-gaap:NoncontrollingInterestMember 2023-12-31 0001679817 OZSC:CommonStockToBeIssuedMember 2022-12-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2022-12-31 0001679817 us-gaap:CommonStockMember 2022-12-31 0001679817 us-gaap:TreasuryStockCommonMember 2022-12-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001679817 us-gaap:RetainedEarningsMember 2022-12-31 0001679817 us-gaap:NoncontrollingInterestMember 2022-12-31 0001679817 2022-12-31 0001679817 OZSC:CommonStockToBeIssuedMember 2024-01-01 2024-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-03-31 0001679817 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001679817 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001679817 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001679817 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2023-01-01 2023-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-03-31 0001679817 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001679817 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001679817 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001679817 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2024-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-03-31 0001679817 us-gaap:CommonStockMember 2024-03-31 0001679817 us-gaap:TreasuryStockCommonMember 2024-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001679817 us-gaap:RetainedEarningsMember 2024-03-31 0001679817 us-gaap:NoncontrollingInterestMember 2024-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2023-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-03-31 0001679817 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-03-31 0001679817 us-gaap:CommonStockMember 2023-03-31 0001679817 us-gaap:TreasuryStockCommonMember 2023-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001679817 us-gaap:RetainedEarningsMember 2023-03-31 0001679817 us-gaap:NoncontrollingInterestMember 2023-03-31 0001679817 2023-03-31 0001679817 2023-05-05 0001679817 OZSC:FinancingAndRegistrationRightsAgreementMember 2023-05-02 2023-05-02 0001679817 OZSC:FinancingAndRegistrationRightsAgreementMember 2023-01-01 2023-12-31 0001679817 OZSC:FinancingAndRegistrationRightsAgreementMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001679817 OZSC:FirstSecuritiesPurchaseAgreementMember OZSC:GHSInvestmentsLLCMember us-gaap:CommonStockMember 2024-01-26 2024-04-26 0001679817 OZSC:FinancingAndRegistrationRightsAgreementMember 2024-01-01 2024-03-31 0001679817 OZSC:FinancingAndRegistrationRightsAgreementMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-04-01 2024-05-15 0001679817 2021-04-30 0001679817 OZSC:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001679817 OZSC:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001679817 OZSC:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001679817 OZSC:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001679817 OZSC:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001679817 OZSC:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001679817 OZSC:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001679817 OZSC:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001679817 OZSC:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001679817 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember OZSC:OneSupplierMember 2023-01-01 2023-03-31 0001679817 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0001679817 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0001679817 srt:MinimumMember OZSC:OfficeFurnitureAndEquipmentMember 2024-03-31 0001679817 srt:MaximumMember OZSC:OfficeFurnitureAndEquipmentMember 2024-03-31 0001679817 OZSC:WarehouseEquipmentMember 2024-03-31 0001679817 OZSC:SourcedAndDistributedProductsMember 2024-01-01 2024-03-31 0001679817 OZSC:SourcedAndDistributedProductsMember 2023-01-01 2023-03-31 0001679817 OZSC:OEDInstallationsMember 2024-01-01 2024-03-31 0001679817 OZSC:OEDInstallationsMember 2023-01-01 2023-03-31 0001679817 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001679817 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001679817 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001679817 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001679817 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001679817 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001679817 us-gaap:ConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001679817 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001679817 OZSC:UnexercisedCommonStockPurchaseWarrantsMember 2024-01-01 2024-03-31 0001679817 OZSC:UnexercisedCommonStockPurchaseWarrantsMember 2023-01-01 2023-03-31 0001679817 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001679817 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-03-31 0001679817 OZSC:PromissoryNotePayableMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNotePayableMember 2023-01-01 2023-03-31 0001679817 us-gaap:OfficeEquipmentMember 2024-03-31 0001679817 us-gaap:OfficeEquipmentMember 2023-12-31 0001679817 us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0001679817 us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0001679817 OZSC:FifteenPercentConvertibleNoteMember 2020-06-10 2020-06-10 0001679817 OZSC:FifteenPercentConvertibleNoteMember 2024-03-31 0001679817 OZSC:FifteenPercentConvertibleNoteMember 2023-12-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001679817 us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001679817 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2024-03-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2024-03-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2023-12-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2023-12-31 0001679817 OZSC:MeasurementInputPriceVolatilityOneMember srt:MinimumMember 2024-03-31 0001679817 OZSC:MeasurementInputPriceVolatilityOneMember srt:MaximumMember 2024-03-31 0001679817 OZSC:MeasurementInputPriceVolatilityOneMember srt:MinimumMember 2023-12-31 0001679817 OZSC:MeasurementInputPriceVolatilityOneMember srt:MaximumMember 2023-12-31 0001679817 us-gaap:MeasurementInputExercisePriceMember srt:MinimumMember 2024-03-31 0001679817 us-gaap:MeasurementInputExercisePriceMember srt:MaximumMember 2024-03-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithWarrantsMember 2023-12-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithConvertibleNotesMember 2023-12-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithWarrantsMember 2024-01-01 2024-03-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithConvertibleNotesMember 2024-01-01 2024-03-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithWarrantsMember 2024-03-31 0001679817 OZSC:DerivativeLiabilitiesAssociatedWithConvertibleNotesMember 2024-03-31 0001679817 OZSC:NotePayableMember 2024-03-31 0001679817 OZSC:NotePayableMember 2023-12-31 0001679817 OZSC:OtherMember 2024-03-31 0001679817 OZSC:OtherMember 2023-12-31 0001679817 OZSC:NotePayableOneMember 2024-03-31 0001679817 OZSC:NotePayableOneMember 2023-12-31 0001679817 OZSC:NotePayableTwoMember 2024-03-31 0001679817 OZSC:NotePayableTwoMember 2023-12-31 0001679817 OZSC:NotePayableThreeMember 2024-03-31 0001679817 OZSC:NotePayableThreeMember 2023-12-31 0001679817 OZSC:NotePayableFourMember 2024-03-31 0001679817 OZSC:NotePayableFourMember 2023-12-31 0001679817 OZSC:NotePayableFiveMember 2024-03-31 0001679817 OZSC:NotePayableFiveMember 2023-12-31 0001679817 OZSC:NotePayableSixMember 2024-03-31 0001679817 OZSC:NotePayableSixMember 2023-12-31 0001679817 OZSC:NotePayableSevenMember 2024-03-31 0001679817 OZSC:NotePayableSevenMember 2023-12-31 0001679817 OZSC:NotePayableMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableOneMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableOneMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableTwoMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableTwoMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableThreeMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableThreeMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableFourMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableFourMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableFiveMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableFiveMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableSixMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableSixMember 2023-01-01 2023-12-31 0001679817 OZSC:NotePayableSevenMember 2024-01-01 2024-03-31 0001679817 OZSC:NotePayableSevenMember 2023-01-01 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2022-11-11 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2022-11-11 2022-11-11 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2023-01-01 2023-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2023-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2022-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchThirtyOneTwoThousandTwentyThreeMember 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2021-12-07 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2021-12-05 2021-12-07 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2021-12-12 2021-12-13 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2022-10-31 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2023-01-01 2023-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:DecemberSevenTwoThousandTwentyTwoMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2021-03-17 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2021-03-16 2021-03-17 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2021-03-23 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2021-03-22 2021-03-23 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchSeventeenTwoThousandTwentyTwoMember 2022-10-31 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchSeventeenTwoThousandTwentyTwoMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:MarchSeventeenTwoThousandTwentyTwoMember 2023-01-01 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember 2023-12-31 0001679817 OZSC:PromissoryNoteOneMember OZSC:LenderMember 2021-02-09 0001679817 OZSC:PromissoryNoteOneMember OZSC:LenderMember 2021-02-08 2021-02-09 0001679817 OZSC:PromissoryNoteOneMember OZSC:LenderMember 2021-02-16 0001679817 OZSC:PromissoryNoteOneMember OZSC:LenderMember 2021-02-15 2021-02-16 0001679817 OZSC:PromissoryNoteTwoMember OZSC:LenderMember 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:FebruaryNineTwoThousandTwentyTwoMember 2022-10-31 2022-10-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:FebruaryNineTwoThousandTwentyTwoMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:LenderMember OZSC:FebruaryNineTwoThousandTwentyTwoMember 2023-01-01 2023-03-31 0001679817 OZSC:PromissoryNoteTwoMember OZSC:LenderMember 2024-03-31 0001679817 OZSC:PromissoryNoteTwoMember OZSC:LenderMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-11-13 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-11-12 2020-11-13 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-11-17 2020-11-20 0001679817 OZSC:HolderMember 2020-11-12 2020-11-13 0001679817 OZSC:HolderMember 2020-11-13 0001679817 OZSC:PromissoryNoteOneMember OZSC:HolderMember 2024-03-31 0001679817 OZSC:PromissoryNoteOneMember OZSC:HolderMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2024-01-01 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2024-03-31 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-11-06 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-11-05 2020-11-06 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-06-23 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-06-20 2020-06-23 0001679817 OZSC:HolderMember 2020-11-06 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2023-11-06 2023-11-06 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2023-11-06 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-08-24 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-08-23 2020-08-24 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-08-22 2020-08-25 0001679817 OZSC:HolderMember 2020-08-23 2020-08-24 0001679817 OZSC:PromissoryNoteMember 2024-03-31 0001679817 OZSC:PromissoryNoteMember 2023-12-31 0001679817 OZSC:PromissoryNoteMember 2024-01-01 2024-03-31 0001679817 OZSC:PowerConversionTechnologiesIncMember OZSC:ExchangeAgreementMember 2020-09-02 0001679817 OZSC:PowerConversionTechnologiesIncMember OZSC:ExchangeAgreementMember 2020-08-30 2020-09-02 0001679817 OZSC:PowerConversionTechnologiesIncMember OZSC:ExchangeAgreementMember 2021-02-25 2021-02-26 0001679817 2022-11-10 2022-11-11 0001679817 OZSC:PromissoryNoteMember 2022-11-10 2022-11-11 0001679817 OZSC:VehicleServiceContractsMember 2024-03-31 0001679817 OZSC:VehicleServiceContractsMember 2023-12-31 0001679817 OZSC:MrConwayMember OZSC:EmploymentAgreementMember 2020-07-01 2020-07-10 0001679817 OZSC:EmploymentAgreementMember OZSC:MrConwayMember 2022-01-01 2022-01-01 0001679817 OZSC:MrConwayMember OZSC:EmploymentAgreementMember 2022-01-01 2022-01-31 0001679817 OZSC:MrConwayMember OZSC:EmploymentAgreementMember 2024-01-01 2024-03-31 0001679817 OZSC:MrConwayMember OZSC:EmploymentAgreementMember 2023-01-01 2023-03-31 0001679817 OZSC:RMAAgreementMember 2021-09-01 2021-09-01 0001679817 OZSC:RMAAgreementMember 2021-09-01 0001679817 OZSC:RMAAgreementMember 2023-01-01 2023-12-31 0001679817 2023-01-01 2023-12-31 0001679817 OZSC:SalmanJChaudhryMember OZSC:SeparationAgreementMember us-gaap:RelatedPartyMember 2019-03-04 0001679817 OZSC:SalmanJChaudhryMember OZSC:SeparationAgreementMember us-gaap:RelatedPartyMember 2024-03-31 0001679817 OZSC:SalmanJChaudhryMember OZSC:SeparationAgreementMember us-gaap:RelatedPartyMember 2023-12-31 0001679817 OZSC:PCTIMember OZSC:AgreementWithThirdPartyMember 2020-09-01 2020-09-02 0001679817 OZSC:PCTIMember OZSC:AmendedAgreementWithThirdPartyMember 2021-02-25 2021-02-26 0001679817 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2024-03-31 0001679817 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-12-31 0001679817 OZSC:SettlementAgreementMember OZSC:WIthinTwoDaysMember us-gaap:SubsequentEventMember 2024-04-04 2024-04-04 0001679817 OZSC:SettlementAgreementMember OZSC:BeforeSixtyDaysMember us-gaap:SubsequentEventMember 2024-04-04 2024-04-04 0001679817 OZSC:SettlementAgreementMember us-gaap:SubsequentEventMember 2024-04-04 2024-04-04 0001679817 OZSC:SettlementAgreementMember us-gaap:SubsequentEventMember 2024-05-02 2024-05-02 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-01-08 2024-01-08 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-01-08 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-01-25 2024-01-25 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-01-25 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-02-12 2024-02-12 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-02-12 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-02-28 2024-02-28 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-02-28 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-03-14 2024-03-14 0001679817 us-gaap:CommonStockMember OZSC:FinancingAndRegistrationRightsAgreementMember 2024-03-14 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:AmendmentCertificatesOfDesignationMember 2020-07-07 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:AmendmentCertificatesOfDesignationMember 2020-07-06 2020-07-07 0001679817 us-gaap:SeriesDPreferredStockMember OZSC:SecuritiesPurchaseAgreementMember OZSC:PCTIMember 2020-07-06 2020-07-10 0001679817 OZSC:MrConwayMember us-gaap:SeriesDPreferredStockMember 2020-08-27 2020-08-28 0001679817 us-gaap:SeriesDPreferredStockMember OZSC:ChisMember 2021-07-01 2021-07-13 0001679817 us-gaap:SeriesDPreferredStockMember OZSC:SeriesDAmendmentMember 2021-07-27 0001679817 us-gaap:InvestorMember us-gaap:SeriesDPreferredStockMember OZSC:SeriesDSPAMember 2021-07-28 2021-07-28 0001679817 us-gaap:InvestorMember us-gaap:SeriesDPreferredStockMember OZSC:SeriesDSPAMember 2021-07-28 0001679817 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001679817 OZSC:RemainingWarrantSharesMember 2024-03-31 0001679817 OZSC:RemainingWarrantSharesMember 2024-01-01 2024-03-31 0001679817 us-gaap:SeriesEPreferredStockMember OZSC:CertificatesOfDesignationMember 2020-07-07 0001679817 OZSC:BrianConwayMember 2021-08-19 0001679817 OZSC:PJNStrategiesMember 2021-08-19 0001679817 OZSC:PJNStrategiesMember 2022-09-12 2022-09-13 0001679817 OZSC:PJNStrategiesMember 2022-09-13 0001679817 2021-04-14 0001679817 stpr:CA 2021-06-01 2021-06-01 0001679817 2021-06-01 0001679817 stpr:CA 2021-04-14 0001679817 us-gaap:AccountingStandardsUpdate201602Member 2021-12-31 0001679817 OZSC:CatherineChisMember us-gaap:LetterOfCreditMember 2022-05-16 0001679817 OZSC:CatherineChisMember 2022-05-16 0001679817 OZSC:PowerConversionTechnologiesIncMember us-gaap:LetterOfCreditMember 2022-06-24 0001679817 OZSC:PowerConversionTechnologiesIncMember 2022-06-24 0001679817 OZSC:GHSInvestmentsLLCMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2024-04-01 2024-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares utr:sqft xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarter ended March 31, 2024

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to __________

 

Commission file number 000-55976

 

OZOP ENERGY SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   3841   35-2540672

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Primary Standard Industrial

Classification Number)

 

(IRS Employer

Identification Number)

 

55 Ronald Reagan Blvd.

Warwick, NY 10990

(877) 785-6967

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Securities registered under Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicated by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. :

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use to the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

As of May 14, 2024, 6,120,103,120 shares of common stock of the registrant were outstanding.

 

 

 

 

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

 

  Page
   
Consolidated Balance Sheets as of March 31, 2024, and December 31, 2023 (Unaudited) F-1
   
Consolidated Statements of Operations for the three months ended March 31, 2024, and 2023 (Unaudited) F-2
   
Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2024, and 2023 (Unaudited) F-3
   
Consolidated Statements of Cash Flows for the three months ended March 31, 2024, and 2023 (Unaudited) F-5
   
Notes to Consolidated Financial Statements (unaudited) F-6

 

2

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   March 31, 2024   December 31, 2023 
ASSETS          
Current Assets          
Cash  $1,154,964   $1,446,029 
Prepaid expenses   80,043    75,103 
Accounts receivable   125,569    168,770 
Inventory   1,027,298    1,089,979 
Total Current Assets   2,387,874    2,779,881 
           
Operating lease right-of-use asset, net   337,036    372,451 
Property and equipment, net   601,443    618,899 
Other assets   13,408    13,408 
TOTAL ASSETS  $3,339,761   $3,784,639 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Liabilities          
Current Liabilities          
Accounts payable and accrued expenses  $8,822,759   $8,026,784 
Convertible notes payable   25,000    25,000 
Current portion of notes payable, net of discounts   19,156,250    18,837,500 
Derivative liabilities   754,073    1,216,078 
Operating lease liability, current portion   151,800    147,993 
Deferred liability   490,855    490,495 
Liabilities of discontinued operations   1,034,811    1,038,384 
Total Current Liabilities   30,435,548    29,782,234 
          
Long Term Liabilities          
Notes payable, net of discount   298,443    284,203 
Operating lease liability, net of current portion   197,197    236,389 
TOTAL LIABILITIES   30,931,188    30,302,826 
           
COMMITMENTS AND CONTINGENCIES   -    - 
           
Stockholders’ Deficit          
Preferred stock (10,000,000 shares authorized, par value $0.001) Series C Preferred Stock (50,000 shares authorized and 2,500 shares issued and outstanding, par value $0.001)   3    3 
Series D Preferred Stock (4,570 shares authorized and 1,334 shares issued and outstanding, par value $0.001)   1    1 
Series E Preferred Stock (3,000 shares authorized, -0- issued and outstanding, par value $0.001)   -    - 
Common stock (6,990,000,000 shares authorized, par value $0.001; 5,821,817,128 and 5,481,513,400 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively)   5,821,817    5,481,513 
Treasury stock, at cost, 47,500 shares of Series C Preferred Stock and 18,667 shares of Series D Preferred Stock   (11,249,934)   (11,249,934)
Common stock to be issued; 637,755 shares   638    638 
Additional paid in capital   198,715,100    198,704,849 
Accumulated deficit   (220,094,275)   (218,670,480)
Total Ozop Energy Solutions, Inc. stockholders’ deficit   (26,806,650)   (25,733,410)
Noncontrolling interest   (784,777)   (784,777)
TOTAL STOCKHOLDERS’ DEFICIT   (27,591,427)   (26,518,187)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $3,339,761   $3,784,639 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-1

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

           
   For the Three Months Ended March 31, 
   2024   2023 
Revenue  $251,722   $2,791,198 
Cost of revenue   115,445    2,394,700 
Gross profit   136,277    396,498 
           
Operating expenses:          
General and administrative, related parties   240,000    240,000 
General and administrative, other   728,763    829,762 
Total operating expenses   968,763    1,069,762 
           
Loss from continuing operations   (832,486)   (673,264)
           
Other (income) expenses:          
Interest expense   1,056,887    1,221,533 
Loss (gain) on change in fair value of derivatives   (462,005)   638,118 
Total Other (Income) Expenses   594,882    1,859,651 
           
Loss from continuing operations before income taxes   (1,427,368)   (2,532,915)
Income tax provision   -    - 
Net loss from continuing operations   (1,427,368)   (2,532,915)
Discontinued Operations:          
Income from discontinued operations   3,573    5,363 
Net loss  $(1,423,795)  $(2,527,552)
           
Loss from contuining operations per share of common stock basic and fully diluted  $(0.00)  $(0.00)
Income from discontinued operations per share of common stock basic and fully diluted  $0.00   $0.00 
Loss per share basic and fully diluted  $(0.00)  $(0.00)
           
Weighted average shares outstanding          
Basic and diluted   5,670,128,359    4,834,943,957 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-2

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED MARCH 31, 2024

(Unaudited)

 

                                                                                                         
    Common stock to be issued     Series C Preferred Stock     Series D Preferred Stock     Common Stock           Additional                 Total
Stockholders’
 
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Treasury Stock     Paid-in
Capital
    Accumulated
Deficit
    Noncontrolling
Interest
    Equity (Deficit)  
Balances January 1, 2024     637,755     $ 638       2,500     $ 3       1,334     $ 1       5,481,513,400     $ 5,481,513     $ (11,249,934 )   $ 198,704,849     $ (218,670,480 )   $ (784,777 )   $   (26,518,187 )
                                                                                                         
Issuance of shares of common stock sold, net of issuance costs of $12,384     -       -       -       -       -       -       340,303,728       340,304       -       10,251       -       -       350,555  
                                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       -       (1,423,795 )     -       (1,423,795 )
Balances March 31, 2024     637,755     $ 638       2,500     $ 3       1,334     $ 1       5,821,817,128     $ 5,821,817     $ (11,249,934 )   $ 198,715,100     $ (220,094,275 )   $ (784,777 )   $ (27,591,427 )

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-3

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED MARCH 31, 2023

(Unaudited)

 

    Common stock to be issued     Series C Preferred Stock     Series D Preferred Stock     Common Stock           Additional                 Total
Stockholders’
 
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Treasury Stock     Paid-in
Capital
    Accumulated
Deficit
    Noncontrolling
Interest
    Equity (Deficit)  
Balances January 1, 2023     637,755     $ 638       2,500     $ 3       1,334     $ 1       4,771,275,349     $ 4,771,275     $ (11,249,934 )   $ 197,586,824     $ (211,300,799 )   $ (784,777 )   $   (20,976,769 )
                                                                                                         
Issuance of shares of common stock sold, net of issuance costs of $19,110     -       -       -       -       -       -       107,756,783       107,757       -       418,636       -       -       526,393  
                                                                                                         
Net income     -       -       -       -       -       -       -       -       -       -       (2,527,552 )     -       (2,527,552 )
Balances March 31, 2023     637,755     $ 638       2,500     $ 3       1,334     $ 1       4,879,032,132     $ 4,879,032     $ (11,249,934 )   $ 198,005,460     $ (213,828,351 )   $ (784,777 )   $ (22,977,928 )

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

OZOP ENERGY SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

           
   For the Three Months Ended March 31, 
   2024   2023 
Cash flows from operating activities:          
Net loss from continuing operations  $(1,427,368)  $(2,532,915)
Net income from discontinued operations   3,573    5,363 
Net loss   (1,423,795)   (2,527,552)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities          
Non-cash interest expense   332,990    500,568 
Amortization and depreciation   52,870    55,912 
(Gain) loss on fair value change of derivatives   (462,005)   638,118 
Changes in operating assets and liabilities:          
Accounts receivable   43,201    (36,270)
Inventory   62,681    1,952,844 
Prepaid expenses   (4,941)   (9,915)
Vendor deposits   -    (633,445)
Accounts payable and accrued expenses   795,977    708,358 
Deferred revenue   360    - 
Operating lease liabilities   (35,385)   (31,882)
Net cash provided by (used in) continuing operations   (638,047)   616,736 
Net cash used in discontinued operations   (3,573)   (5,363)
Net cash provided by (used in) operating activities   (641,620)   611,373 
           
Cash flows from investing activities:          
Purchase of office and computer equipment   -    (2,162)
Net cash used in investing activities   -    (2,162)
           
Cash flows from financing activities:          
Proceeds from sale of common stock, net of costs   350,555    526,393 
Payments of principal of notes payable   -    (550,000)
Net cash provided by (used in) financing activities   350,555    (23,607)
           
Net increase (decrease) in cash   (291,065)   585,604 
           
Cash, Beginning of period   1,446,029    1,369,210 
           
Cash, End of period  $1,154,964   $1,954,814 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

OZOP ENERGY SOLUTIONS, INC.

Notes to Consolidated Financial Statements

March 31, 2024

(Unaudited)

 

NOTE 1 - ORGANIZATION

 

Business

 

Ozop Energy Solutions, Inc. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

 

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation (“Merger Sub”). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company’s name to “Ozop Energy Solutions, Inc.” That same day the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Merger Sub and filed Articles of Merger (the “Articles of Merger”) with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to “Ozop Energy Solutions, Inc.”

 

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. (“OES”), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

 

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation and a wholly owned subsidiary of the Company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

 

On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

 

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

 

On May 5, 2023, the Board of Directors of the Company approved to amend the Company’s Articles of Incorporation (the “Amendment”) to increase the authorized capital stock of the Company to 7,000,000,000 shares, of which 6,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the Amendment with the State of Nevada on June 23, 2023.

 

NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS

 

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2024, the Company had an accumulated deficit of $220,094,275 and a working capital deficit of $28,047,674 (including derivative liabilities of $754,073). As of March 31, 2024, the Company was in default of $3,315,000 plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

F-6

 

 

Management’s Plans

 

As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market.

 

On May 2, 2023, the Company entered into an Equity Financing Agreement (the “Financing Agreement”) and Registration Rights Agreement (the “Registration Rights Agreement”) with GHS. Under the terms of the Financing Agreement, GHS has agreed to provide the Company with up to $10,000,000 of funding upon effectiveness of a registration statement on Form S-1. Pursuant to the effectiveness of the registration statement on July 19, 2023, the Company has the right to deliver puts to GHS and GHS will be obligated to purchase shares of our common stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed two hundred fifty percent (250%) of the average of the daily trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company’s common stock to GHS that would result in GHS’s beneficial ownership equaling more than 4.99% of the Company’s outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company’s common stock for the ten (10) consecutive trading days preceding the date on which the applicable put is delivered to GHS. No put will be made in an amount equaling less than $10,000 or greater than $750,000. Puts may be delivered by the Company to GHS until the earlier of twenty-four (24) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares. During the year ended December 31, 2023, the Company sold to GHS 587,432,649 shares of common stock and received $1,230,043 net of offering costs. During the three months ended March 31, 2024, the Company sold to GHS 146,517,693 shares of common stock for proceeds of $172,117 net of offering costs.

 

On January 26, 2024, the Company receive a Notice of Effectiveness for the sale of up to One Billion (1,000,000,000) shares of the Company’s common stock to GHS, pursuant to the May 2, 2023, Financing Agreement and Registration Rights Agreement. The terms and conditions are similar to the terms and conditions of the July 19, 2023, registration statement. During the quarter ended March 31, 2024, the Company sold to GHS 193,786,035 shares of common stock and received $178,438, net of offering costs. Subsequent to March 31, 2024, the Company has sold to GHS 298,285,992 shares of common stock for proceeds of $187,995, net of offering costs.

 

OES operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution.

 

Equipment Distributor: In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility. OES currently is focused on solar panel sales to other distributors and large installation companies.

 

Modular Energy Distribution System: The Neo-GridTM System comprises of the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. The Company has acquired the license rights to the Neo-GridTM System, a proprietary system (patent pending), for the capture and distribution of electrical energy for the EV market. The Neo-GridTM System will serve both the private auto and the commercial sectors. Our Neo-GridTM System offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

 

F-7

 

 

The Company has developed a business plan for the Neo-GridTM System for the distribution of electrical energy providing a solution to the inevitable stress to the existing grid infrastructure. The Company has completed its’ research and development of the Neo-GridTM System as well as completed the first set of engineered technical drawings. This first stage of the engineered technical drawings allows us to move forward with stage two, as well as to begin to construct the first prototype or proof of concept, (“PoC”). Our PoC design is partially reliant on auto manufacturers establishing standardizations of the actual charging/discharging protocols of the batteries such as on-board inverters as well as bi-directional capabilities in electric vehicles, which have only recently been established.

 

Ozop Plus markets vehicle service contracts (“VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC’s will give “peace of mind” to the EV buyer.

 

OED is developing a product branded OZOP ARC. OZOP ARC is an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, OZOP ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management.

 

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on April 16, 2024.

 

The unaudited consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries Ozop Capital Partners, Inc., Ozop Engineering and Design, Inc., Power Conversion Technologies, Inc. (“PCTI”), Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”).

 

F-8

 

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2024, and December 31, 2023.

 

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2024, and 2023, and their accounts receivable balance as of March 31, 2024:

 

   Sales % Three Months Ended March 31, 2024   Sales % Three Months Ended March 31, 2023   Accounts receivable balance March 31, 2024 
Customer A   67%   -   $39,800 
Customer B   10%   -   $39,679 
Customer C   -    97%  $- 

 

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventory

 

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs consist of finished goods. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Finished goods inventories as of March 31, 2024, and December 31, 2023, were $1,027,298 and $1,089,979, respectively. Based on current market conditions related to solar panels including but not limited to reduced selling prices in the industry and the abundance of inventory supply in the market, management determined that the net realizable value of certain of the Company’s inventory required a lower of cost or market adjustment of $1,495,978 to the historical cost of inventory purchases for the year ended December 31, 2023. There are no inventory markdowns for the three months ended March 31, 2024, and 2023.

 

Purchase concentration

 

OES purchases finished renewable energy products from its suppliers. For the three months ended March 31, 2023, there was one supplier that accounted for 100%. For the three months ended March 31, 2024, the Company made no purchases.

 

F-9

 

 

Property, plant, and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

  Building 10-25 years
  Office furniture and equipment 3-5 years
  Warehouse equipment 7 years

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products or providing services by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms for product sales or upon delivery of service to the customer for installation services. Any advance payments are recorded as current liability until revenue is recognized.

 

For product sales contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges.

 

For installation services contracts with customers, the Company invoices the customer upon completion of the job and recognizes revenue based on the invoiced amount.

 

The following table disaggregates our revenue by major source for the three months ended March 31, 2024, and 2023:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Sourced and distributed products  $75,222   $2,758,798 
OED Installations   176,500    32,400 
Total  $251,722   $2,791,198 

 

Revenues from sourced and distributed products were previously purchased from suppliers as finished goods and were either in the Carlsbad warehouse or in a third-party warehouse.

 

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2024, and 2023, the Company recorded advertising and marketing expenses of $15,671 and $17,772, respectively.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

F-10

 

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023. For additional information, see Note 14- Discontinued Operations.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

F-11

 

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity, or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in the fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses and certain notes payable, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2024, and December 31, 2023, for each fair value hierarchy level:

 

March 31, 2024  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $754,073   $754,073 

 

December 31, 2023  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $1,216,078   $1,216,078 

 

F-12

 

 

Leases

 

The Company accounts for leases under ASU 2016-02 (see Note 13), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

 

Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the unaudited consolidated statements of operations.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

 

Segment Policy

 

The Company has no reportable segments as it operates in one segment: renewable energy.

 

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2024, and 2023, the Company’s dilutive securities are convertible into approximately 10,280,235,000 and 8,471,310,904 shares of common stock respectively. The following table represents the classes of dilutive securities as of March 31, 2024, and 2023:

 

   March 31, 2024   March 31, 2023 
Convertible preferred stock (1)   8,732,725,692    7,318,548,198 
Unexercised common stock purchase warrants (1)   807,024,518    1,047,024,518 
Convertible notes payable (1)   72,738,215    11,025,635 
Promissory notes payable (1)   667,746,575    94,712,553 
Total   10,280,235,000    8,471,310,904 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.

 

F-13

 

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows.

 

Other than the above, there have been no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2024, that are of significance or potential significance to the Company.

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

The following table summarizes the Company’s property and equipment:

 

   March 31, 2024   December 31, 2023 
Office equipment  $224,733   $224,733 
Building and building improvements   600,000    600,000 
           
Less: Accumulated Depreciation   (223,290)   (205,834)
Property and Equipment, Net  $601,443   $618,899 

 

Depreciation expenses were $17,456 and $23,022 for the three months ended March 31, 2024, and 2023, respectively.

 

NOTE 5 - CONVERTIBLE NOTES PAYABLE

 

On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $25,000.

 

NOTE 6 – DERIVATIVE LIABILITIES

 

The Company determined the conversion feature of the convertible notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.

 

At any given time, certain of the Company’s embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date.

 

The Company valued the derivative liabilities as of March 31, 2024, and December 31, 2023, at $754,073 and $1,216,078 respectively. For the derivative liability associated with convertible notes, the Company used the Monte Carlo simulation valuation model with the following assumptions as of March 31, 2024 and December 31, 2023, risk free interest rates at 5.38% and 5.26%, respectively, and volatility of 88% and 48%, respectively.

 

F-14

 

 

The following assumptions were utilized in the Black-Scholes valuation of outstanding warrants as of March 31, 2024, and December 31, 2023, risk free interest rates of 4.48% to 5.38%, and 4.3% to 5.26%, respectively, volatility of 85% to 115%, and 48% to 99%, respectively, and exercise prices of $0.0019 to $0.15.

 

A summary of the activity related to derivative liabilities for the three months ended March 31, 2024, is as follows:

 

   Derivative liabilities associated with warrants   Derivative liabilities associated with convertible notes   Total derivative liabilities 
             
Balance January 1, 2024  $1,187,076   $29,002   $1,216,078 
Change in fair value   (465,157)   3,152    (462,005)
Balance March 31, 2024  $721,919   $32,154   $754,073 

 

NOTE 7 – NOTES PAYABLE

 

The Company has the following notes payable outstanding:

 

   March 31, 2024   December 31, 2023 
         
Note payable, interest at 8%, matured January 5, 2020, in default  $45,000   $45,000 
Other, due on demand, interest at 6%, currently in default   50,000    50,000 
Note payable $750,000 face value, interest at 12%, matured August 24, 2021, in default   375,000    375,000 
Note payable $389,423 face value, interest at 15%, matures November 6, 2025, net of discount of $90,980 (2024) and $105,220 (2023)   298,443    284,203 
Note payable $1,000,000 face value, interest at 12%, matured November 13, 2021, in default   1,000,000    1,000,000 
Note payable $2,200,000 face value, interest at 15%, matures October 31, 2024, net of discount of $99,167 (2024) and $141,667 (2023)   2,100,833    2,058,333 
Note payable $11,110,000 face value, interest at 15%, matures October 31, 2024, net of discount of $495,833 (2024) and $708,333 (2023)   10,614,167    10,401,667 
Note payable $3,300,000 face value, interest at 15%, matures October 31, 2024, net of discount of $148,750 (2024) and $212,500 (2023)   3,151,250    3,087,500 
Note payable $3,020,000 face value, matured March 31, 2023, in default   1,820,000    1,820,000 
Sub- total notes payable, net of discount   19,454,693    19,121,703 
Less long-term portion, net of discount   298,443    284,203 
Current portion of notes payable, net of discount  $19,156,250   $18,837,500 

 

F-15

 

 

On November 11, 2022, the Company entered into a non-interest bearing, $3,020,000 face value promissory note with a third-party lender with scheduled weekly payments and a maturity date of March 31, 2023. In exchange for the issuance of the $3,020,000 note, inclusive of an original issue discount of $250,000, and the reclass of $260,000 from accounts payable and accrued expenses the Company received proceeds of $2,510,000 on November 11, 2022, from the lender. For the three months ended March 31, 2023, amortization of the original issue discount of $181,818 was charged to interest expense. The original issue discount of $250,000 has been fully amortized as of March 31, 2023. The Company has repaid total $1,200,000 of the principal of the note through March 31, 2024, including $250,000 during the year ended December 31, 2022, and $950,000 during the year ended December 31, 2023 (among which, $550,000 was repaid during the three months ended March 31, 2023). As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $1,820,000 and $1,820,000, respectively. The Company is in default on the weekly payments. The Company is currently in discussions with the lender regarding an extension of the maturity date.

 

On December 7, 2021, the Company entered into a 12%, $3,300,000 face value promissory note with a third- party lender with a maturity date of December 7, 2022. In exchange for the issuance of the $3,300,000 note, inclusive of an original issue discount of $300,000, the Company received proceeds of $3,000,000 on December 13, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 75,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $510,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $63,750 and $63,750 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $3,300,000 with carrying values of $3,151,250 and $3,087,500, respectively, net of unamortized discounts of $148,750 and $212,500 as of March 31, 2024, and December 31, 2023, respectively.

 

On March 17, 2021, the Company entered into a 12%, $11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022. In exchange for the issuance of the $11,110,000 note, inclusive of an original issue discount of $1,000,000 and lender costs of $110,000 the Company received proceeds of $10,000,000 on March 23, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 250,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $1,700,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $212,500 and $212,500 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $11,110,000 with a carrying value of $10,614,167 and $10,401,667, respectively, net of unamortized discounts of $495,833 and $708,333, respectively.

 

On February 9, 2021, the Company entered into a 12%, $2,200,000 face value promissory note with a third- party lender with a maturity date of February 9, 2022. In exchange for the issuance of the $2,200,000 note, inclusive of an original issue discount of $200,000 the Company received proceeds of $2,000,000 on February 16, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 50,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $340,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $42,500 and $42,500 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $2,200,000 with a carrying value of $2,100,833 and $2,058,333, respectively, net of unamortized discounts of $99,167 and $141,667, respectively.

 

On November 13, 2020, the Company entered into a 12%, $1,000,000 face value promissory note with a third-party due November 13, 2021. Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Company received proceeds of $890,000 on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $110,000. In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 125,000,000 shares of common stock at an exercise price of $0.008, subject to adjustments and expires on the five-year anniversary of the issue date. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $1,000,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2024, and December 31, 2023, the accrued interest is $675,452 and $615,452, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

 

F-16

 

 

On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $120,000 of convertible notes with accrued and unpaid interest of $8,716 and a $210,000 Promissory Note dated June 23, 2020, with accrued and unpaid interest of $15,707. The Company issued a new 12% Promissory Note with a face value of $389,423 and a maturity date of November 6, 2023. In conjunction with this settlement, the Company issued a warrant to purchase 60,000,000 shares of common stock at an exercise price of $0.0075, subject to adjustments and expires on the five-year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021. On November 6, 2023, the maturity date of the note was extended to November 6, 2025, and the interest rate was increased to 15% per annum. The Company issued 60,000,000 warrants at an exercise price of $0.0019 and with an expiration of November 6, 2026, in exchange for the extension. The warrants were valued at $113,921 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, $14,240 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $389,423 with a carrying value of $298,443 and $284,203, respectively, net of unamortized discounts of $90,980 and $105,220, respectively.

 

On August 24, 2020 (the “Issue Date”), the Company entered into a 12%, $750,000 face value promissory note with a third-party (the “Holder”) due August 24, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $663,000 on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $87,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 122,950,819 shares of common stock at an exercise price of $0.0061, subject to adjustments and expires on the five-year anniversary of the Issue Date. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $375,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2024, and December 31, 2023, the accrued interest is $292,747 and $270,247, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

 

NOTE 8 – DEFERRED LIABILITY

 

On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8%.

 

No payments have been made and the Company is in default of the agreement. On November 11, 2022, the third-party and the Company agreed to reduce the liability by $260,000 and add $260,000 to the promissory note issued on November 11, 2022.

 

EV Insurance Company records premiums received from the issuance of Vehicle Service Contracts (“VSC’s”) as a deferred liability. The Company will analyze the deferred liability to determine if any amounts can be recorded as income with the balance remaining in deferred liabilities or potential future claims. As of March 31, 2024, and December 31, 2023, the Company has recorded $855 and $495 as deferred liabilities related to VSC’s.

 

The deferred liability as of March 31, 2024, and December 31, 2023, on the consolidated balance sheets is $490,855 and $490,495, respectively.

 

F-17

 

 

NOTE 9 – RELATED PARTY TRANSACTIONS

 

Employment Agreement

 

On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Mr. Conway’s compensation as adjusted was $20,000 per month. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway will receive annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month. For the three months ended March 31, 2024, and 2023, the Company recorded expenses to Mr. Conway of $240,000 for each period.

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Agreements

 

On September 1, 2021, Ozop Capital entered into an advisory agreement (the “RMA Agreement”) with Risk Management Advisors, Inc. (“RMA”). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital’s participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company’s participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. The fee for these services was $100,000. Ozop Capital agreed to pay $50,000 and to issue $50,000 of shares of restricted common stock. The parties agreed to a reduced fee of $48,000 for the year ended December 31, 2023, which has been accrued as of March 31, 2024, and December 31, 2023, and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein. As of March 31, 2024, and December 31, 2023, the Company has recorded 637,755 shares of common stock to be issued for the balance owed, in addition to the $48,000.

 

On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. As of March 31, 2024, and December 31, 2023, the balance owed Mr. Chaudhry is $162,085.

 

On September 2, 2020, PCTI entered into an Agreement with a third-party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8% (see Note 8). As of March 31, 2024, and December 31, 2023, the Company has recorded $243,272, respectively, and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein.

 

F-18

 

 

Legal matters

 

We know of no material, existing or pending legal proceedings against our Company.

 

We are involved as a plaintiff in a Complaint filed in the SUPERIOR COURT OF THE STATE OF CALIFORNIA FOR THE COUNTY OF SAN DIEGO NORTH COUNTY (the “Complaint”) on November 14, 2022. The Complaint alleges that former employees would place an order from a customer for purchase of product from OZOP with funds the exact source of which is presently unknown. OZOP alleges that next, the customer would sell that product to OZOP’s customers at a price marked up from the price for which the customer purchased from OZOP – to the benefit of Defendants and to the detriment of OZOP, their employer at the time. The Complaint further alleges that the former employees falsely represented that the price the customer was obtaining from other suppliers and therefore was willing to pay for OZOP product decreased, which allowed them to use the customer to then sell additional product to OZOP’s customers at increasingly larger margins, thus further wrongfully enriching themselves to the detriment of their employer, OZOP. The lawsuit also alleges that the employees were also making false statements to Ozop’s customers regarding the financial condition of Ozop and the lack of module inventory.

 

On April 4, 2024, the Company executed a Settlement Agreement (the “Settlement”) with its former employees and Your Home Solutions Corp (“YHS”). YHS and the former employees were all defendants (the “Defendants”) in the Complaint. Pursuant to the terms of the Settlement, the Defendants are to pay the Company $500,000 within 2 days of the Settlement and $625,000 on or before sixty (60) days from the Settlement. In exchange, the Company agreed to release all Defendants from the lawsuit upon the final and full payment of $1,125,000 and to deliver 11 containers of solar panels. As of May 2, 2024, the Company received the $1,125,000, and the Company has released the 11 containers by May 6, 2024 (see Note 16).

 

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

NOTE 11– STOCKHOLDERS’ EQUITY

 

Common stock

 

During the three months ended March 31, 2024, the Company issued 340,303,728 shares of common stock and received net proceeds of $350,555 after issuance costs of $12,384, as follows:

 

On January 8, 2024, the Company sold 85,134,032 shares to GHS at $0.00128 and received net proceeds of $105,767, after deducting transaction and broker fees of $3,204.

 

On January 25, 2024, the Company sold 61,383,661 shares to GHS at $0.00112 and received net proceeds of $66,350, after deducting transaction and broker fees of $2,400.

 

On February 12, 2024, the Company sold 60,722,962 shares to GHS at $0.00104 and received net proceeds of $60,864, after deducting transaction and broker fees of $2,288.

 

On February 28, 2024, the Company sold 62,124,323 shares to GHS at $0.00096 and received net proceeds of $57,422, after deducting transaction and broker fees of $2,218.

 

On March 14, 2024, the Company sold 70,938,750 shares to GHS at $0.00088 and received net proceeds of $60,152, after deducting transaction and broker fees of $2,274.

 

During the three months ended March 31, 2023, the Company issued 107,756,783 shares of common stock and received net proceeds of $526,393 after issuance costs of $19,110.

 

As of March 31, 2024, the Company has 6,990,000,000 shares of $0.001 par value common stock authorized and there are 5,821,817,128 shares of common stock issued and outstanding.

 

Preferred stock

 

As of March 31, 2024, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

 

F-19

 

 

Series C Preferred Stock

 

On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote. As of March 31, 2024, and December 31, 2023, there were 2,500 shares of Series C Preferred Stock issued and outstanding and the shares are held by Mr. Conway.

 

Series D Preferred Stock

 

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667 shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway’s employment agreement, the Company issued 1,333 shares of Series D Preferred Stock to Mr. Conway. On July 13, 2021, the Company purchased 18,667 shares of the Company’s Series D Preferred Stock held by Chis.

 

On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the “Series D Amendment”). Under the terms of the Series D Amendment, 4,570 shares of the Company’s preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock and multiply that result by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the “Series D SPA”). Pursuant to the terms of Series D SPA, an investor in exchange for $13,200,000 purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236 shares of Series D Preferred Stock. As of March 31, 2024, and December 31, 2023, there were 1,334 shares, respectively, of Series D Preferred Stock issued and outstanding and a warrant to purchase 3,236 shares of Series D Preferred Stock are outstanding as of March 31, 2024, and December 31, 2023.

 

The warrant has a 15- year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows:

 

  i. Up to 162 (one hundred and sixty-two) Warrant Shares, at any time or times on or after five (5) business days from the closing of the Series D SPA (“the Initial Exercise Date”) subject to up to a maximum number of Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company and no later than on or before the 15th year anniversary of the Initial Exercise Date (“the Termination Date”); and
     
  ii. The Remainder of the Warrant representing up to 3,074 (three thousand and seventy-four) Warrant Shares (“Remaining Warrant Shares”) shall be locked up for a period of 36 (thirty-six) months from the Initial Exercise Date (“Lock Up Period”) and shall become exercisable at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date (“Lock Up Period Termination Date”) and no later than on or before the Termination Date, as follows:

 

  a. During every 1 (one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034, and until the Termination Date.

 

F-20

 

 

Series E Preferred Stock

 

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. As of March 31, 2024, and December 31, 2023, there were -0- shares of Series E Preferred Stock issued and outstanding, respectively.

 

NOTE 12 – NONCONTROLLING INTEREST

 

On August 19, 2021, the Company formed Ozop Capital. The Company initially owned 51% with PJN Holdings, LLC (“PJN”) owning 49%. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the unaudited consolidated financial statements. On September 13, 2022, there was a change in the ownership percentages, as PJN returned 490,000 shares, representing their 49% ownership. As of that date, Ozop Capital is a wholly owned subsidiary of the Company. As of March 31, 2024, and December 31, 2023, the accumulative noncontrolling interest is $784,777.

 

NOTE 13 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES

 

On April 14, 2021, the Company entered into a five-year lease which began on June 1, 2021, for approximately 8,100 square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026. Initial lease payments of $13,148 begin on June 1, 2021, and increase by approximately 2.4% annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $702,888 for this lease. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility.

 

In adopting Topic 842, the Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.

 

F-21

 

 

Right-of-use assets are summarized below:

   March 31, 2024   December 31, 2023 
Office and warehouse lease  $702,888   $702,888 
Less: Accumulated amortization   (365,852)   (330,437)
Right-of-use assets, net  $337,036   $372,451 

 

Operating lease liabilities are summarized as follows:

   March 31, 2024   December 31, 2023 
Lease liability  $348,997   $384,382 
Less current portion   (151,800)   (147,993)
Long term portion  $197,197   $236,389 

 

Maturity of lease liabilities are as follows:

   Amount 
For the year ending December 31, 2024 (remaining period)  $129,468 
For the year ending December 31, 2025   175,942 
For the year ended December 31, 2026   74,030 
Total  $379,440 
Less: present value discount   (30,443)
Lease liability  $348,997 

 

The Company recorded $29 and $28,701 operating lease expense (after netting off the sublease income) for the three months ended March 31, 2024, and 2023, respectively.

 

NOTE 14 – DISCONTINUED OPERATIONS

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023. On October 3, 2022, PCTI filed a Voluntary Petition for Non- Individuals Filing for Bankruptcy. On November 30, 2022, the Trustee filed a Notice of Abandonment of Estate Property, as it is over encumbered by the secured creditors. No objections were filed, and as such the inventory and equipment is now considered abandoned to the secured creditors to do with what they wish. In March 2023, the Trustee declared this a no-asset case and closed the bankruptcy.

 

The results of operations of this component, for all periods, are separately reported as “discontinued operations”. A reconciliation of the major classes of line items constituting the income (loss) from discontinued operations, net of income taxes as is presented in the unaudited Consolidated Statements of Operations for the three months ended March 31, 2024, and 2023, are summarized below:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Revenues  $3,573   $5,363 
Cost of goods sold   -    - 
Gross profit   3,573    5,363 
Operating expenses   -    - 
Interest expense   -    - 
Income from discontinued operations  $3,573   $5,363 

 

F-22

 

 

There are no assets as of March 31, 2024, and December 31, 2023, as the secured lender has taken possession. Liabilities of discontinued operations are separately reported as of March 31, 2024, and December 31, 2023. All liabilities are classified as current. The following tables present the reconciliation of carrying amounts of the major classes of liabilities of the Company classified as discontinued operations in the consolidated balance sheets at March 31, 2024, and December 31, 2023:

 

Current liabilities

 

   March 31,
2024
   December 31,
2023
 
Accounts payable and accrued liabilities  $445,565   $445,565 
Current portion of notes payable   589,246    589,246 
Deferred revenues   -    3,573 
Total current liabilities of discontinued operations  $1,034,811   $1,038,384 

 

On May 16, 2022, Huntington National Bank (“Huntington”) filed a Complaint for Confession of Judgment (“COJ”) against Catherine Chis (“Chis”). Chis was the former CEO of PCTI and a Guarantor on Huntington’s Letter of Credit financing (“LOC”) and a Term Loan (“Term Loan”). The Chis COJ for the LOC was $352,415 and accrues per diem interest of $63.65, and the Chis COJ for the Term Loan was $141,415 and accrues per diem interest of $28.60. On June 24, 2022, Huntington filed a COJ against Power Conversion Technologies, Inc (“PCTI”). The PCTI COJ for the LOC was for $354,774 and accrues per diem interest of $63.65 and the PCTI COJ for the LOC was for $142,473 and accrues per diem interest of $28.60. On July 20, 2022, Huntington assigned the PCTI judgment against PCTI to Meraki Advisors, LLC. (“Meraki”). The Company’s understanding is Meraki is a Pennsylvania limited liability company, controlled by Chis.

 

Included in the Current portion of notes payable are the principal balances of Huntington’s LOC of $344,166 and Term Loan of $134,681. Accrued interest and fees on the LOC and Term Loan debt $54,256 is included in accounts payable and accrued liabilities.

 

NOTE 15 - INCOME TAXES

 

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely- than not that some or all of the deferred tax assets will not be realized.

 

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of March 31, 2024, and December 31, 2023.

 

NOTE 16 – SUBSEQUENT EVENTS

 

From April 1, 2024, through the filing of this report, the Company sold to GHS 298,285,992 shares of common stock for proceeds of $187,995 net of offering costs.

 

On April 4, 2024, the Company executed a Settlement Agreement (the “Settlement”) with its former employees (see Note 10) and Your Home Solutions Corp (“YHS”). YHS and the former employees were all defendants (the “Defendants”) in the Complaint. Pursuant to the terms of the Settlement, the Defendants are to pay the Company $500,000 within 2 days of the Settlement and $625,000 on or before sixty (60) days from the Settlement. In exchange, the Company agreed to release all Defendants from the lawsuit upon the final and full payment of $1,125,000 and to deliver 11 containers of solar panels. As of May 2, 2024, the Company has received the $1,125,000, and the Company has released the 11 containers by May 6, 2024.

 

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

 

F-23

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

 

While our financial statements are presented on the basis that we are a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable length of time, our auditors have raised a substantial doubt about our ability to continue as a going concern.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

 

The following discussion should be read in conjunction with our unaudited consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

 

THE COMPANY

 

Ozop Energy Solutions, Inc. (the “Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

 

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. (“OES”), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

 

OES operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution.

 

Equipment Distributor: In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility. OES currently is focused on solar panel sales to other distributors and large installation companies.

 

Modular Energy Distribution System: The Neo-GridTM System comprises of the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. The Company has acquired the license rights to the Neo-GridTM System, a proprietary system (patent pending), for the capture and distribution of electrical energy for the EV market. The Neo-GridTM System will serve both the private auto and the commercial sectors. Our Neo-GridTM System offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

 

3

 

 

The Company has developed a business plan for the Neo-GridTM System for the distribution of electrical energy providing a solution to the inevitable stress to the existing grid infrastructure. The Company has completed its’ research and development of the Neo-GridTM System as well as completed the first set of engineered technical drawings. This first stage of the engineered technical drawings allows us to move forward with stage two, as well as to begin to construct the first prototype or proof of concept, (“PoC”). Our PoC design is partially reliant on auto manufacturers establishing standardizations of the actual charging/discharging protocols of the batteries such as on-board inverters as well as bi-directional capabilities in electric vehicles, which have only recently been established.

 

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation and a wholly owned subsidiary of the Company and was formed as a holding company. On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurer that reinsures in the State of Delaware. EVCO (DBA “OZOP Plus”) is a wholly owned subsidiary of Ozop Capital.

 

Ozop Plus markets vehicle service contracts (“VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC’s will give “peace of mind” to the EV buyer.

 

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners can offer the resources needed for lighting, solar and electrical design projects. OED will provide its’ customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs by working with architects, engineers, facility managers, electrical contractors and engineers.

 

OED is developing a product branded OZOP ARC. OZOP ARC is an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, OZOP ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management.

 

Discontinued Operations

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023.

 

4

 

 

Results of Operations for the three months ended March 31, 2024, and 2023:

 

Revenue

 

For the three months ended March 31, 2024, the Company generated revenue of $251,722 compared to $2,791,198 for the three months ended March 31, 2023. Revenues from Ozop Energy Systems, Inc. (“OES”) are classified as sourced and distributed products. Revenues from Ozop Engineering and Design (“OED”) are classified as design and installation. Sales are summarized as follows:

 

   Three months ended
March 31,
 
   2024   2023 
Sourced and distributed products  $75,222   $2,758,798 
Design and installation   176,500    32,400 
Total  $251,722   $2,791,198 

 

Sales of sourced and distributed products (solar product) were significantly lower for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. The Company believes the lower revenues were due to higher interest rates affecting homeowners’ ability and desire for residential rooftop solar installations as well as competitors lowering their selling prices to try to capture a part of the lower demand. These factors also resulted in our customers having excess inventory on hand. Design and installation revenues increased for the three months ended March 31, 2024, as the Company received additional and larger installation jobs.

 

Cost of sales

 

For the three months ended March 31, 2024, and 2023, the Company recognized $115,445 and $2,394,700, respectively, of cost of sales.

 

   Three months ended
March 31,
 
   2024   2023 
Sourced and distributed products  $63,331   $2,394,700 
Design and installation   52,114    - 
Total  $115,445   $2,394,700 

 

During the year ended December 31, 2023, the Company reviewed its inventory valuation to determine if the historical cost of its solar panels was less than their net realizable value. Management also considers, if applicable, other factors, including known trends, market conditions, and other such issues. Based on current market conditions related to solar panels including but not limited to reduced selling prices in the industry and the abundance of inventory supply in the market, management determined that the net realizable value of certain of the Company’s inventory required a lower of cost or market adjustment of $1,495,978 (the “Inventory Adjustment”) to the historical cost of inventory purchased.

 

Pursuant to the Inventory Adjustment, the Company recognized a gross margin on solar products of 15.8% for the three months ended March 31, 2024, compared to 13.2% for the three months ended March 31, 2023.

 

Design and installation cost of sales is comprised of OED’s labor costs for each job.

 

Operating expenses

 

Total operating expenses for the three months ended March 31, 2024, and 2023, were $968,763 and $1,069,762 respectively. The operating expenses were comprised of:

 

   Three months ended March 31, 
   2024   2023 
Management fees, related parties  $240,000   $240,000 
Salaries, taxes, and benefits   193,494    266,804 
Professional and consulting fees   254,827    281,008 
Advertising and marketing   15,671    17,772 
Rent and office expenses   83,604    55,116 
Insurance   60,976    48,391 
General and administrative, other   120,191    160,671 
Total  $968,763   $1,069,762 

 

5

 

 

On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Mr. Conway’s compensation as adjusted was $20,000 per month. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway will receive annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month. For the three months ended March 31, 2024, and 2023, the Company recorded expenses to Mr. Conway of $240,000 or each period.

 

Salaries, taxes, and benefits decreased for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. Ozop Energy Systems currently has 2 employees with an aggregate annual salary of $204,000 and focused on information technology and general and administrative functions. The solar distribution of this vertical is being managed by our financial consultant and the Company’s CEO. OED currently has five employees with an aggregate annual compensation of $478,000 and a daily consultant when needed. OED has allocated $52,114 of salaries to cost of sales for the three months ended March 31, 2024. EV Insurance Company has one employee with annual compensation of $125,000. The expenses per subsidiary included in operating expenses for the three months ended March 31, 2024, and 2023, are as follows:

 

   Three months ended March 31, 
   2024   2023 
Ozop Energy Systems  $55,637   $79,701 
Ozop Engineering and Design   103,716    152,852 
EV Insurance Company   34,141    34,251 
Total  $193,494   $266,804 

 

Professional and consulting fees decreased for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. The decrease is due to the expiration of certain consulting contracts and legal fees related to the YHS litigation. These decreases were partially offset by increases in general legal expenses and auditing fees.

 

Advertising and marketing expenses decreased for the three months ended March 31, 2024, compared to the three months ended March 31, 2023.

 

Rent and office expense (including storage, supplies, utilities, and internet costs) increased for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. The increase is the result of $55,890 expenses incurred by OES for storage fees, partially offset by decreased rent expense that on March 1, 2023, OES has subleased the Carlsbad office and warehouse to a third party.

 

Insurance expense increased for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. The increase was the result of increases in the Company’s general liability insurance. The Company estimates that the monthly insurance expense to be approximately $20,000 per month.

 

6

 

 

Other (Income) Expenses

 

Other expense, net, for the three months ended March 31, 2024, was $594,882 compared to $1,859,651 for the three months ended March 31, 2023, and were as follows.

 

  

Three months ended

March 31,

 
   2024   2023 
Interest expense  $1,056,887   $1,221,533 
(Gain) loss on change in fair value of derivatives   (462,005)   638,118 
Total other (income) expense, net  $594,882   $1,859,651 

 

The decrease in interest expense for the three months ended March 31, 2024, is primarily a result of the amortization period of certain note discounts that were completed in 2023. Interest expense on the face value of the principal balances of the notes payable increased due to the increased rate as a result of note defaults and extended maturity dates. For the three months ended March 31, 2024, the Company recognized a gain of $462,005 on the change in the fair value of derivatives compared to a loss of $638,118 for the three months ended March 31, 2023.

 

Net loss

 

Net loss attributable to the Company for the three months ended March 31, 2024, was $1,423,795 compared to $2,527,552 for the three months ended March 31, 2023. The change was primarily a result of the gain of $462,005 on the change in fair value of derivatives for the three months ended March 31, 2024, compared to a loss of $638,115 for the three months ended March 31, 2023. The decrease in gross profit for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, partially offset the gain on the change in the fair value of derivatives.

 

Liquidity and Capital Resources

 

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2024, the Company had an accumulated deficit of $220,094,725 and a working capital deficit of $28,047,674 (including derivative liabilities of $754,073). As of March 31, 2024, the Company was in default of $3,315,000 plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

Currently, our current capital and our other existing resources will be sufficient to provide the working capital needed for our current business, however, additional capital will be required to meet our debt obligations, and to further expand our business. We may be unable to obtain the additional capital required. If we are unable to generate capital or raise additional funds when required, it will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations, deficit in equity, and the need to raise additional capital to fund operations. This “going concern” could impair our ability to finance our operations through the sale of debt or equity securities. Management’s plans in regard to these factors are discussed in Note 2 to the unaudited consolidated financial statements filed herein.

 

For the three months ended March 31, 2024, we primarily funded our business operations with the existing cash on hand as of January 1, 2024, cash received from accounts receivable, and $350,555 received from sales of common stock.

 

As of March 31, 2024, we had cash of $1,154,964 as compared to $1,446,029 as of December 31, 2023. As of March 31, 2024, we had current liabilities of $30,435,548 (including $754,073 of derivative liabilities), compared to current assets of $2,387,874, which resulted in a working capital deficit of $28,047,674. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, derivative liabilities, lease obligations, deferred liability, notes payable and liabilities of discontinued operations.

 

7

 

 

Operating Activities

 

For the three months ended March 31, 2024, net cash used in operating activities was $641,620 compared to net cash provided by operating activities of $611,373 for the three months ended March 31, 2023.

 

For the three months ended March 31, 2024, our net cash used in operating activities was primarily attributable to the net loss of $1,423,795, the gain on the change in fair value of derivatives of $462,005, adjusted by non-cash items of interest expense of $332,990, and amortization and depreciation of $52,870. Net changes of $861,893 in operating assets and liabilities reduced the cash used in operating activities.

 

For the three months ended March 31, 2023, our net cash provided by operating activities was primarily attributable to the net loss of $2,527,552, adjusted by non-cash items of the loss on the fair value change of derivatives of $638,118, interest expense of $500,568, and amortization and depreciation of $55,912. Net changes of $1,949,690 in operating assets and liabilities added to the cash provided by operating activities.

 

Investing Activities

 

There were no investing activities for the three months ended March 31, 2024. For the three months ended March 31, 2023, the net cash used in investing activities was $2,162.

 

Financing Activities

 

For the three months ended March 31, 2024, the net cash provided by financing activities was $350,555, net of issuance costs, from the sales of common stock to GHS.

 

For the three months ended March 31, 2023, the net cash used in financing activities was $23,607. During the three months ended March 31, 2023, we received $526,393, net of issuance costs, from the sales of common stock to GHS. During the three months ended March 31, 2023, we made payments of $550,000 for notes payable.

 

Critical Accounting Policies and Estimates

 

Our significant accounting policies are described in more details in the notes to our financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. We believe the following accounting policies to be most critical to the judgement and estimates used in the preparation of our financial statements:

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

8

 

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

OFF BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements, including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not Applicable.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of March 31, 2024. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of March 31, 2024, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

 

  1. We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.
     
  2. We did not maintain appropriate cash controls – As of March 31, 2024, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

Changes in Internal Controls over Financial Reporting

 

There has been no change in our internal control over financial reporting during the three months ended March 31, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

9

 

 

PART II. OTHER INFORMATION

 

Item 1. LEGAL PROCEEDINGS

 

We know of no material, existing or pending legal proceedings against our Company. We are involved as a plaintiff in a Complaint filed in the SUPERIOR COURT OF THE STATE OF CALIFORNIA FOR THE COUNTY OF SAN DIEGO NORTH COUNTY (the “Complaint”) on November 14, 2022. The Complaint alleges that former employees would place an order from a customer for purchase of product from OZOP with funds the exact source of which is presently unknown. OZOP alleges that next, the customer would sell that product to OZOP’s customers at a price marked up from the price for which the customer purchased from OZOP – to the benefit of Defendants and to the detriment of OZOP, their employer at the time. The Complaint further alleges that the former employees falsely represented that the price the customer was obtaining from other suppliers and therefore was willing to pay for OZOP product decreased, which allowed them to use the customer to then sell additional product to OZOP’s customers at increasingly larger margins, thus further wrongfully enriching themselves to the detriment of their employer, OZOP. The lawsuit also alleges that the employees were also making false statements to Ozop’s customers regarding the financial condition of Ozop and the lack of module inventory. On April 4, 2024, the Company executed a Settlement Agreement (the “Settlement”) with its former employees and Your Home Solutions Corp (“YHS”). YHS and the former employees were all defendants (the “Defendants”) in the Complaint. Pursuant to the terms of the Settlement, the Defendants are to pay the Company $500,000 within 2 days of the Settlement and $625,000 on or before sixty (60) days from the Settlement. In exchange, the Company agreed to release all Defendants from the lawsuit upon the final and full payment of $1,125,000 and to deliver 11 containers of solar panels. As of May 2, 2024, the Company has received the $1,125,000, and the Company has released the 11 containers by May 6, 2024.

 

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

Item 1A. RISK FACTORS

 

Not applicable for smaller reporting companies.

 

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

Item 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

Item 4. MINE SAFETY DISCLOSURE

 

Not applicable.

 

Item 5. OTHER INFORMATION

 

  (a) None.
  (b) During the quarter ended March 31, 2024, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

 

10

 

 

Item 6. EXHIBITS

 

The following documents are filed as part of this report:

 

Exhibit No.   Description
     
2.1   Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).
     
2.2   Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).
     
2.3   Merger Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).
     
3.1   Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
     
3.2   Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
     
3.3   Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).
     
3.4   Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019).
     
3.5   Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019).
     
3.6   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).
     
3.7   Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019).
     
3.8   Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019).
     
3.9   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).
     
3.10   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).
     
3.11   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).
     
3.12   Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).

 

11

 

 

3.13   Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020).
     
3.14   Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020).
     
3.15   Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020).
     
3.16   Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020).
     
3.17   Articles of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020).
     
3.18   Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021).
     
3.19   Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021)
     
10.1   Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).
     
10.2+   Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020).
     
31.1*   Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2*   Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*   Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63

 

101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

+ Management contract or compensatory plan or arrangement.

 

12

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: May 14, 2024

 

/s/  Brian P Conway  
Brian P. Conway  
Chief Executive Officer  
(principal executive officer)  
(principal financial and accounting officer)  

 

13

 

Exhibit 31.1

 

CERTIFICATION

 

I, Brian P. Conway, Chief Executive Officer of OZOP ENERGY SOLUTIONS, INC. (the “registrant”), certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended March 31, 2024;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024

 

/s/ Brian P. Conway  
Brian P Conway  
Chief Executive Officer  
(principal executive officer)  

 

 

 

Exhibit 31.2

 

CERTIFICATION

 

I, Brian P. Conway, Interim Chief Financial Officer of OZOP ENERGY SOLUTIONS, INC. (the “registrant”), certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended March 31, 2024;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024

 

/s/ Brian P Conway  
Brian P Conway  
Interim Chief Financial Officer  
(principal financial and accounting officer)  

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Each of the undersigned hereby certifies, in his capacity as an officer of OZOP ENERGY SOLUTIONS, INC. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2024, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 14, 2024

 

/s/ Brian P Conway  
Brian P. Conway  
Chief Executive Officer  
(principal executive officer)  
(principal financial and accounting officer)  

 

 

v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 14, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 000-55976  
Entity Registrant Name OZOP ENERGY SOLUTIONS, INC.  
Entity Central Index Key 0001679817  
Entity Tax Identification Number 35-2540672  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 55 Ronald Reagan Blvd.  
Entity Address, City or Town Warwick  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10990  
City Area Code (877)  
Local Phone Number 785-6967  
Title of 12(g) Security Common Stock, $0.001 par value  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,120,103,120
v3.24.1.1.u2
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash $ 1,154,964 $ 1,446,029
Prepaid expenses 80,043 75,103
Accounts receivable 125,569 168,770
Inventory 1,027,298 1,089,979
Total Current Assets 2,387,874 2,779,881
Operating lease right-of-use asset, net 337,036 372,451
Property and equipment, net 601,443 618,899
Other assets 13,408 13,408
TOTAL ASSETS 3,339,761 3,784,639
Current Liabilities    
Accounts payable and accrued expenses 8,822,759 8,026,784
Convertible notes payable 25,000 25,000
Current portion of notes payable, net of discounts 19,156,250 18,837,500
Derivative liabilities 754,073 1,216,078
Operating lease liability, current portion 151,800 147,993
Deferred liability 490,855 490,495
Liabilities of discontinued operations 1,034,811 1,038,384
Total Current Liabilities 30,435,548 29,782,234
Long Term Liabilities    
Notes payable, net of discount 298,443 284,203
Operating lease liability, net of current portion 197,197 236,389
TOTAL LIABILITIES 30,931,188 30,302,826
COMMITMENTS AND CONTINGENCIES
Stockholders’ Deficit    
Preferred stock, value 3 3
Common stock (6,990,000,000 shares authorized, par value $0.001; 5,821,817,128 and 5,481,513,400 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively) 5,821,817 5,481,513
Treasury stock, at cost, 47,500 shares of Series C Preferred Stock and 18,667 shares of Series D Preferred Stock (11,249,934) (11,249,934)
Common stock to be issued; 637,755 shares 638 638
Additional paid in capital 198,715,100 198,704,849
Accumulated deficit (220,094,275) (218,670,480)
Total Ozop Energy Solutions, Inc. stockholders’ deficit (26,806,650) (25,733,410)
Noncontrolling interest (784,777) (784,777)
TOTAL STOCKHOLDERS’ DEFICIT (27,591,427) (26,518,187)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 3,339,761 3,784,639
Series D Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock, value 1 1
Series E Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock, value
v3.24.1.1.u2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 6,990,000,000 6,990,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 5,821,817,128 5,481,513,400
Common stock, shares outstanding 5,821,817,128 5,481,513,400
Common stock to be issued 637,755 637,755
Series C Preferred Stock [Member]    
Preferred stock, shares authorized 50,000 50,000
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares outstanding 2,500 2,500
Preferred stock, shares issued 2,500 2,500
Treasury stock, shares 47,500 47,500
Series D Preferred Stock [Member]    
Preferred stock, shares authorized 4,570 4,570
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares outstanding 1,334 1,334
Preferred stock, shares issued 1,334 1,334
Treasury stock, shares 18,667 18,667
Series E Preferred Stock [Member]    
Preferred stock, shares authorized 3,000 3,000
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares outstanding 0 0
Preferred stock, shares issued 0 0
v3.24.1.1.u2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 251,722 $ 2,791,198
Cost of revenue 115,445 2,394,700
Gross profit 136,277 396,498
Operating expenses:    
General and administrative, related parties 240,000 240,000
General and administrative, other 728,763 829,762
Total operating expenses 968,763 1,069,762
Loss from continuing operations (832,486) (673,264)
Other (income) expenses:    
Interest expense 1,056,887 1,221,533
Loss (gain) on change in fair value of derivatives (462,005) 638,118
Total Other (Income) Expenses 594,882 1,859,651
Loss from continuing operations before income taxes (1,427,368) (2,532,915)
Income tax provision
Net loss from continuing operations (1,427,368) (2,532,915)
Discontinued Operations:    
Income from discontinued operations 3,573 5,363
Net loss $ (1,423,795) $ (2,527,552)
Income (loss) from contuining operations per share of common stock basic $ (0.00) $ (0.00)
Income (loss) from contuining operations per share of common stock fully diluted (0.00) (0.00)
Income (loss) from discontinued operations per share of common stock basic 0.00 0.00
Income (loss) from discontinued operations per share of common stock fully diluted 0.00 0.00
Income (loss) per share basic (0.00) (0.00)
Income (loss) per share fully diluted $ (0.00) $ (0.00)
Weighted average shares outstanding    
Weighted average shares outstanding Basic 5,670,128,359 4,834,943,957
Weighted average shares outstanding Diluted 5,670,128,359 4,834,943,957
v3.24.1.1.u2
Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)
Common Stock To Be Issued [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2022 $ 638 $ 3 $ 1 $ 4,771,275 $ (11,249,934) $ 197,586,824 $ (211,300,799) $ (784,777) $ (20,976,769)
Balance, shares at Dec. 31, 2022 637,755 2,500 1,334 4,771,275,349          
Issuance of shares of common stock sold, net of issuance costs $ 107,757 418,636 526,393
Issuance of shares of common stock sold, net of issuance costs, shares       107,756,783          
Net income (loss) (2,527,552) (2,527,552)
Balance at Mar. 31, 2023 $ 638 $ 3 $ 1 $ 4,879,032 (11,249,934) 198,005,460 (213,828,351) (784,777) (22,977,928)
Balance, shares at Mar. 31, 2023 637,755 2,500 1,334 4,879,032,132          
Balance at Dec. 31, 2022 $ 638 $ 3 $ 1 $ 4,771,275 (11,249,934) 197,586,824 (211,300,799) (784,777) (20,976,769)
Balance, shares at Dec. 31, 2022 637,755 2,500 1,334 4,771,275,349          
Balance at Dec. 31, 2023 $ 638 $ 3 $ 1 $ 5,481,513 (11,249,934) 198,704,849 (218,670,480) (784,777) (26,518,187)
Balance, shares at Dec. 31, 2023 637,755 2,500 1,334 5,481,513,400          
Issuance of shares of common stock sold, net of issuance costs $ 340,304 10,251 350,555
Issuance of shares of common stock sold, net of issuance costs, shares       340,303,728          
Net income (loss) (1,423,795) (1,423,795)
Balance at Mar. 31, 2024 $ 638 $ 3 $ 1 $ 5,821,817 $ (11,249,934) $ 198,715,100 $ (220,094,275) $ (784,777) $ (27,591,427)
Balance, shares at Mar. 31, 2024 637,755 2,500 1,334 5,821,817,128          
v3.24.1.1.u2
Consolidated Statement of Stockholders' Deficit (Unaudited) (Parenthetical) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Issuance cost $ 12,384 $ 19,110
v3.24.1.1.u2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net loss from continuing operations $ (1,427,368) $ (2,532,915)  
Net income from discontinued operations 3,573 5,363  
Net loss (1,423,795) (2,527,552)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities      
Non-cash interest expense 332,990 500,568  
Amortization and depreciation 52,870 55,912  
(Gain) loss on fair value change of derivatives (462,005) 638,118  
Changes in operating assets and liabilities:      
Accounts receivable 43,201 (36,270)  
Inventory 62,681 1,952,844  
Prepaid expenses (4,941) (9,915)  
Vendor deposits (633,445)  
Accounts payable and accrued expenses 795,977 708,358  
Deferred revenue 360  
Operating lease liabilities (35,385) (31,882)  
Net cash provided by (used in) continuing operations (638,047) 616,736  
Net cash used in discontinued operations (3,573) (5,363)  
Net cash provided by (used in) operating activities (641,620) 611,373  
Cash flows from investing activities:      
Purchase of office and computer equipment (2,162)  
Net cash used in investing activities (2,162)  
Cash flows from financing activities:      
Proceeds from sale of common stock, net of costs 350,555 526,393 $ 48,000
Payments of principal of notes payable (550,000)  
Net cash provided by (used in) financing activities 350,555 (23,607)  
Net increase (decrease) in cash (291,065) 585,604  
Cash, Beginning of period 1,446,029 1,369,210 1,369,210
Cash, End of period 1,154,964 1,954,814 $ 1,446,029
Supplemental disclosure of cash flow information:      
Cash paid for interest  
Cash paid for income taxes  
v3.24.1.1.u2
ORGANIZATION
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION

NOTE 1 - ORGANIZATION

 

Business

 

Ozop Energy Solutions, Inc. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

 

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation (“Merger Sub”). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company’s name to “Ozop Energy Solutions, Inc.” That same day the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Merger Sub and filed Articles of Merger (the “Articles of Merger”) with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to “Ozop Energy Solutions, Inc.”

 

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. (“OES”), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

 

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation and a wholly owned subsidiary of the Company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

 

On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

 

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

 

On May 5, 2023, the Board of Directors of the Company approved to amend the Company’s Articles of Incorporation (the “Amendment”) to increase the authorized capital stock of the Company to 7,000,000,000 shares, of which 6,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the Amendment with the State of Nevada on June 23, 2023.

 

v3.24.1.1.u2
GOING CONCERN AND MANAGEMENT’S PLANS
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN AND MANAGEMENT’S PLANS

NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS

 

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2024, the Company had an accumulated deficit of $220,094,275 and a working capital deficit of $28,047,674 (including derivative liabilities of $754,073). As of March 31, 2024, the Company was in default of $3,315,000 plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

 

Management’s Plans

 

As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market.

 

On May 2, 2023, the Company entered into an Equity Financing Agreement (the “Financing Agreement”) and Registration Rights Agreement (the “Registration Rights Agreement”) with GHS. Under the terms of the Financing Agreement, GHS has agreed to provide the Company with up to $10,000,000 of funding upon effectiveness of a registration statement on Form S-1. Pursuant to the effectiveness of the registration statement on July 19, 2023, the Company has the right to deliver puts to GHS and GHS will be obligated to purchase shares of our common stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed two hundred fifty percent (250%) of the average of the daily trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company’s common stock to GHS that would result in GHS’s beneficial ownership equaling more than 4.99% of the Company’s outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company’s common stock for the ten (10) consecutive trading days preceding the date on which the applicable put is delivered to GHS. No put will be made in an amount equaling less than $10,000 or greater than $750,000. Puts may be delivered by the Company to GHS until the earlier of twenty-four (24) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares. During the year ended December 31, 2023, the Company sold to GHS 587,432,649 shares of common stock and received $1,230,043 net of offering costs. During the three months ended March 31, 2024, the Company sold to GHS 146,517,693 shares of common stock for proceeds of $172,117 net of offering costs.

 

On January 26, 2024, the Company receive a Notice of Effectiveness for the sale of up to One Billion (1,000,000,000) shares of the Company’s common stock to GHS, pursuant to the May 2, 2023, Financing Agreement and Registration Rights Agreement. The terms and conditions are similar to the terms and conditions of the July 19, 2023, registration statement. During the quarter ended March 31, 2024, the Company sold to GHS 193,786,035 shares of common stock and received $178,438, net of offering costs. Subsequent to March 31, 2024, the Company has sold to GHS 298,285,992 shares of common stock for proceeds of $187,995, net of offering costs.

 

OES operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution.

 

Equipment Distributor: In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility. OES currently is focused on solar panel sales to other distributors and large installation companies.

 

Modular Energy Distribution System: The Neo-GridTM System comprises of the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. The Company has acquired the license rights to the Neo-GridTM System, a proprietary system (patent pending), for the capture and distribution of electrical energy for the EV market. The Neo-GridTM System will serve both the private auto and the commercial sectors. Our Neo-GridTM System offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

 

 

The Company has developed a business plan for the Neo-GridTM System for the distribution of electrical energy providing a solution to the inevitable stress to the existing grid infrastructure. The Company has completed its’ research and development of the Neo-GridTM System as well as completed the first set of engineered technical drawings. This first stage of the engineered technical drawings allows us to move forward with stage two, as well as to begin to construct the first prototype or proof of concept, (“PoC”). Our PoC design is partially reliant on auto manufacturers establishing standardizations of the actual charging/discharging protocols of the batteries such as on-board inverters as well as bi-directional capabilities in electric vehicles, which have only recently been established.

 

Ozop Plus markets vehicle service contracts (“VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC’s will give “peace of mind” to the EV buyer.

 

OED is developing a product branded OZOP ARC. OZOP ARC is an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, OZOP ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management.

 

v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on April 16, 2024.

 

The unaudited consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries Ozop Capital Partners, Inc., Ozop Engineering and Design, Inc., Power Conversion Technologies, Inc. (“PCTI”), Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”).

 

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2024, and December 31, 2023.

 

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2024, and 2023, and their accounts receivable balance as of March 31, 2024:

 

   Sales % Three Months Ended March 31, 2024   Sales % Three Months Ended March 31, 2023   Accounts receivable balance March 31, 2024 
Customer A   67%   -   $39,800 
Customer B   10%   -   $39,679 
Customer C   -    97%  $- 

 

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventory

 

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs consist of finished goods. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Finished goods inventories as of March 31, 2024, and December 31, 2023, were $1,027,298 and $1,089,979, respectively. Based on current market conditions related to solar panels including but not limited to reduced selling prices in the industry and the abundance of inventory supply in the market, management determined that the net realizable value of certain of the Company’s inventory required a lower of cost or market adjustment of $1,495,978 to the historical cost of inventory purchases for the year ended December 31, 2023. There are no inventory markdowns for the three months ended March 31, 2024, and 2023.

 

Purchase concentration

 

OES purchases finished renewable energy products from its suppliers. For the three months ended March 31, 2023, there was one supplier that accounted for 100%. For the three months ended March 31, 2024, the Company made no purchases.

 

 

Property, plant, and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

  Building 10-25 years
  Office furniture and equipment 3-5 years
  Warehouse equipment 7 years

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products or providing services by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms for product sales or upon delivery of service to the customer for installation services. Any advance payments are recorded as current liability until revenue is recognized.

 

For product sales contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges.

 

For installation services contracts with customers, the Company invoices the customer upon completion of the job and recognizes revenue based on the invoiced amount.

 

The following table disaggregates our revenue by major source for the three months ended March 31, 2024, and 2023:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Sourced and distributed products  $75,222   $2,758,798 
OED Installations   176,500    32,400 
Total  $251,722   $2,791,198 

 

Revenues from sourced and distributed products were previously purchased from suppliers as finished goods and were either in the Carlsbad warehouse or in a third-party warehouse.

 

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2024, and 2023, the Company recorded advertising and marketing expenses of $15,671 and $17,772, respectively.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023. For additional information, see Note 14- Discontinued Operations.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity, or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in the fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses and certain notes payable, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2024, and December 31, 2023, for each fair value hierarchy level:

 

March 31, 2024  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $754,073   $754,073 

 

December 31, 2023  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $1,216,078   $1,216,078 

 

 

Leases

 

The Company accounts for leases under ASU 2016-02 (see Note 13), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

 

Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the unaudited consolidated statements of operations.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

 

Segment Policy

 

The Company has no reportable segments as it operates in one segment: renewable energy.

 

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2024, and 2023, the Company’s dilutive securities are convertible into approximately 10,280,235,000 and 8,471,310,904 shares of common stock respectively. The following table represents the classes of dilutive securities as of March 31, 2024, and 2023:

 

   March 31, 2024   March 31, 2023 
Convertible preferred stock (1)   8,732,725,692    7,318,548,198 
Unexercised common stock purchase warrants (1)   807,024,518    1,047,024,518 
Convertible notes payable (1)   72,738,215    11,025,635 
Promissory notes payable (1)   667,746,575    94,712,553 
Total   10,280,235,000    8,471,310,904 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.

 

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows.

 

Other than the above, there have been no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2024, that are of significance or potential significance to the Company.

 

v3.24.1.1.u2
PROPERTY AND EQUIPMENT
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 4 – PROPERTY AND EQUIPMENT

 

The following table summarizes the Company’s property and equipment:

 

   March 31, 2024   December 31, 2023 
Office equipment  $224,733   $224,733 
Building and building improvements   600,000    600,000 
           
Less: Accumulated Depreciation   (223,290)   (205,834)
Property and Equipment, Net  $601,443   $618,899 

 

Depreciation expenses were $17,456 and $23,022 for the three months ended March 31, 2024, and 2023, respectively.

 

v3.24.1.1.u2
CONVERTIBLE NOTES PAYABLE
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
CONVERTIBLE NOTES PAYABLE

NOTE 5 - CONVERTIBLE NOTES PAYABLE

 

On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $25,000.

 

v3.24.1.1.u2
DERIVATIVE LIABILITIES
3 Months Ended
Mar. 31, 2024
Derivative Liabilities  
DERIVATIVE LIABILITIES

NOTE 6 – DERIVATIVE LIABILITIES

 

The Company determined the conversion feature of the convertible notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.

 

At any given time, certain of the Company’s embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date.

 

The Company valued the derivative liabilities as of March 31, 2024, and December 31, 2023, at $754,073 and $1,216,078 respectively. For the derivative liability associated with convertible notes, the Company used the Monte Carlo simulation valuation model with the following assumptions as of March 31, 2024 and December 31, 2023, risk free interest rates at 5.38% and 5.26%, respectively, and volatility of 88% and 48%, respectively.

 

 

The following assumptions were utilized in the Black-Scholes valuation of outstanding warrants as of March 31, 2024, and December 31, 2023, risk free interest rates of 4.48% to 5.38%, and 4.3% to 5.26%, respectively, volatility of 85% to 115%, and 48% to 99%, respectively, and exercise prices of $0.0019 to $0.15.

 

A summary of the activity related to derivative liabilities for the three months ended March 31, 2024, is as follows:

 

   Derivative liabilities associated with warrants   Derivative liabilities associated with convertible notes   Total derivative liabilities 
             
Balance January 1, 2024  $1,187,076   $29,002   $1,216,078 
Change in fair value   (465,157)   3,152    (462,005)
Balance March 31, 2024  $721,919   $32,154   $754,073 

 

v3.24.1.1.u2
NOTES PAYABLE
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 7 – NOTES PAYABLE

 

The Company has the following notes payable outstanding:

 

   March 31, 2024   December 31, 2023 
         
Note payable, interest at 8%, matured January 5, 2020, in default  $45,000   $45,000 
Other, due on demand, interest at 6%, currently in default   50,000    50,000 
Note payable $750,000 face value, interest at 12%, matured August 24, 2021, in default   375,000    375,000 
Note payable $389,423 face value, interest at 15%, matures November 6, 2025, net of discount of $90,980 (2024) and $105,220 (2023)   298,443    284,203 
Note payable $1,000,000 face value, interest at 12%, matured November 13, 2021, in default   1,000,000    1,000,000 
Note payable $2,200,000 face value, interest at 15%, matures October 31, 2024, net of discount of $99,167 (2024) and $141,667 (2023)   2,100,833    2,058,333 
Note payable $11,110,000 face value, interest at 15%, matures October 31, 2024, net of discount of $495,833 (2024) and $708,333 (2023)   10,614,167    10,401,667 
Note payable $3,300,000 face value, interest at 15%, matures October 31, 2024, net of discount of $148,750 (2024) and $212,500 (2023)   3,151,250    3,087,500 
Note payable $3,020,000 face value, matured March 31, 2023, in default   1,820,000    1,820,000 
Sub- total notes payable, net of discount   19,454,693    19,121,703 
Less long-term portion, net of discount   298,443    284,203 
Current portion of notes payable, net of discount  $19,156,250   $18,837,500 

 

 

On November 11, 2022, the Company entered into a non-interest bearing, $3,020,000 face value promissory note with a third-party lender with scheduled weekly payments and a maturity date of March 31, 2023. In exchange for the issuance of the $3,020,000 note, inclusive of an original issue discount of $250,000, and the reclass of $260,000 from accounts payable and accrued expenses the Company received proceeds of $2,510,000 on November 11, 2022, from the lender. For the three months ended March 31, 2023, amortization of the original issue discount of $181,818 was charged to interest expense. The original issue discount of $250,000 has been fully amortized as of March 31, 2023. The Company has repaid total $1,200,000 of the principal of the note through March 31, 2024, including $250,000 during the year ended December 31, 2022, and $950,000 during the year ended December 31, 2023 (among which, $550,000 was repaid during the three months ended March 31, 2023). As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $1,820,000 and $1,820,000, respectively. The Company is in default on the weekly payments. The Company is currently in discussions with the lender regarding an extension of the maturity date.

 

On December 7, 2021, the Company entered into a 12%, $3,300,000 face value promissory note with a third- party lender with a maturity date of December 7, 2022. In exchange for the issuance of the $3,300,000 note, inclusive of an original issue discount of $300,000, the Company received proceeds of $3,000,000 on December 13, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 75,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $510,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $63,750 and $63,750 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $3,300,000 with carrying values of $3,151,250 and $3,087,500, respectively, net of unamortized discounts of $148,750 and $212,500 as of March 31, 2024, and December 31, 2023, respectively.

 

On March 17, 2021, the Company entered into a 12%, $11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022. In exchange for the issuance of the $11,110,000 note, inclusive of an original issue discount of $1,000,000 and lender costs of $110,000 the Company received proceeds of $10,000,000 on March 23, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 250,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $1,700,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $212,500 and $212,500 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $11,110,000 with a carrying value of $10,614,167 and $10,401,667, respectively, net of unamortized discounts of $495,833 and $708,333, respectively.

 

On February 9, 2021, the Company entered into a 12%, $2,200,000 face value promissory note with a third- party lender with a maturity date of February 9, 2022. In exchange for the issuance of the $2,200,000 note, inclusive of an original issue discount of $200,000 the Company received proceeds of $2,000,000 on February 16, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 50,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $340,000 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, and 2023, $42,500 and $42,500 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $2,200,000 with a carrying value of $2,100,833 and $2,058,333, respectively, net of unamortized discounts of $99,167 and $141,667, respectively.

 

On November 13, 2020, the Company entered into a 12%, $1,000,000 face value promissory note with a third-party due November 13, 2021. Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Company received proceeds of $890,000 on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $110,000. In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 125,000,000 shares of common stock at an exercise price of $0.008, subject to adjustments and expires on the five-year anniversary of the issue date. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $1,000,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2024, and December 31, 2023, the accrued interest is $675,452 and $615,452, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

 

 

On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $120,000 of convertible notes with accrued and unpaid interest of $8,716 and a $210,000 Promissory Note dated June 23, 2020, with accrued and unpaid interest of $15,707. The Company issued a new 12% Promissory Note with a face value of $389,423 and a maturity date of November 6, 2023. In conjunction with this settlement, the Company issued a warrant to purchase 60,000,000 shares of common stock at an exercise price of $0.0075, subject to adjustments and expires on the five-year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021. On November 6, 2023, the maturity date of the note was extended to November 6, 2025, and the interest rate was increased to 15% per annum. The Company issued 60,000,000 warrants at an exercise price of $0.0019 and with an expiration of November 6, 2026, in exchange for the extension. The warrants were valued at $113,921 by the Black-Scholes option pricing method and will be amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2024, $14,240 was charged to interest expense. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $389,423 with a carrying value of $298,443 and $284,203, respectively, net of unamortized discounts of $90,980 and $105,220, respectively.

 

On August 24, 2020 (the “Issue Date”), the Company entered into a 12%, $750,000 face value promissory note with a third-party (the “Holder”) due August 24, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $663,000 on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $87,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 122,950,819 shares of common stock at an exercise price of $0.0061, subject to adjustments and expires on the five-year anniversary of the Issue Date. As of March 31, 2024, and December 31, 2023, the outstanding principal balance of this note was $375,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2024, and December 31, 2023, the accrued interest is $292,747 and $270,247, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

 

v3.24.1.1.u2
DEFERRED LIABILITY
3 Months Ended
Mar. 31, 2024
Deferred Liability  
DEFERRED LIABILITY

NOTE 8 – DEFERRED LIABILITY

 

On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8%.

 

No payments have been made and the Company is in default of the agreement. On November 11, 2022, the third-party and the Company agreed to reduce the liability by $260,000 and add $260,000 to the promissory note issued on November 11, 2022.

 

EV Insurance Company records premiums received from the issuance of Vehicle Service Contracts (“VSC’s”) as a deferred liability. The Company will analyze the deferred liability to determine if any amounts can be recorded as income with the balance remaining in deferred liabilities or potential future claims. As of March 31, 2024, and December 31, 2023, the Company has recorded $855 and $495 as deferred liabilities related to VSC’s.

 

The deferred liability as of March 31, 2024, and December 31, 2023, on the consolidated balance sheets is $490,855 and $490,495, respectively.

 

 

v3.24.1.1.u2
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 9 – RELATED PARTY TRANSACTIONS

 

Employment Agreement

 

On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Mr. Conway’s compensation as adjusted was $20,000 per month. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway will receive annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month. For the three months ended March 31, 2024, and 2023, the Company recorded expenses to Mr. Conway of $240,000 for each period.

 

v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Agreements

 

On September 1, 2021, Ozop Capital entered into an advisory agreement (the “RMA Agreement”) with Risk Management Advisors, Inc. (“RMA”). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital’s participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company’s participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. The fee for these services was $100,000. Ozop Capital agreed to pay $50,000 and to issue $50,000 of shares of restricted common stock. The parties agreed to a reduced fee of $48,000 for the year ended December 31, 2023, which has been accrued as of March 31, 2024, and December 31, 2023, and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein. As of March 31, 2024, and December 31, 2023, the Company has recorded 637,755 shares of common stock to be issued for the balance owed, in addition to the $48,000.

 

On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. As of March 31, 2024, and December 31, 2023, the balance owed Mr. Chaudhry is $162,085.

 

On September 2, 2020, PCTI entered into an Agreement with a third-party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8% (see Note 8). As of March 31, 2024, and December 31, 2023, the Company has recorded $243,272, respectively, and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein.

 

 

Legal matters

 

We know of no material, existing or pending legal proceedings against our Company.

 

We are involved as a plaintiff in a Complaint filed in the SUPERIOR COURT OF THE STATE OF CALIFORNIA FOR THE COUNTY OF SAN DIEGO NORTH COUNTY (the “Complaint”) on November 14, 2022. The Complaint alleges that former employees would place an order from a customer for purchase of product from OZOP with funds the exact source of which is presently unknown. OZOP alleges that next, the customer would sell that product to OZOP’s customers at a price marked up from the price for which the customer purchased from OZOP – to the benefit of Defendants and to the detriment of OZOP, their employer at the time. The Complaint further alleges that the former employees falsely represented that the price the customer was obtaining from other suppliers and therefore was willing to pay for OZOP product decreased, which allowed them to use the customer to then sell additional product to OZOP’s customers at increasingly larger margins, thus further wrongfully enriching themselves to the detriment of their employer, OZOP. The lawsuit also alleges that the employees were also making false statements to Ozop’s customers regarding the financial condition of Ozop and the lack of module inventory.

 

On April 4, 2024, the Company executed a Settlement Agreement (the “Settlement”) with its former employees and Your Home Solutions Corp (“YHS”). YHS and the former employees were all defendants (the “Defendants”) in the Complaint. Pursuant to the terms of the Settlement, the Defendants are to pay the Company $500,000 within 2 days of the Settlement and $625,000 on or before sixty (60) days from the Settlement. In exchange, the Company agreed to release all Defendants from the lawsuit upon the final and full payment of $1,125,000 and to deliver 11 containers of solar panels. As of May 2, 2024, the Company received the $1,125,000, and the Company has released the 11 containers by May 6, 2024 (see Note 16).

 

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

v3.24.1.1.u2
STOCKHOLDERS’ EQUITY
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 11– STOCKHOLDERS’ EQUITY

 

Common stock

 

During the three months ended March 31, 2024, the Company issued 340,303,728 shares of common stock and received net proceeds of $350,555 after issuance costs of $12,384, as follows:

 

On January 8, 2024, the Company sold 85,134,032 shares to GHS at $0.00128 and received net proceeds of $105,767, after deducting transaction and broker fees of $3,204.

 

On January 25, 2024, the Company sold 61,383,661 shares to GHS at $0.00112 and received net proceeds of $66,350, after deducting transaction and broker fees of $2,400.

 

On February 12, 2024, the Company sold 60,722,962 shares to GHS at $0.00104 and received net proceeds of $60,864, after deducting transaction and broker fees of $2,288.

 

On February 28, 2024, the Company sold 62,124,323 shares to GHS at $0.00096 and received net proceeds of $57,422, after deducting transaction and broker fees of $2,218.

 

On March 14, 2024, the Company sold 70,938,750 shares to GHS at $0.00088 and received net proceeds of $60,152, after deducting transaction and broker fees of $2,274.

 

During the three months ended March 31, 2023, the Company issued 107,756,783 shares of common stock and received net proceeds of $526,393 after issuance costs of $19,110.

 

As of March 31, 2024, the Company has 6,990,000,000 shares of $0.001 par value common stock authorized and there are 5,821,817,128 shares of common stock issued and outstanding.

 

Preferred stock

 

As of March 31, 2024, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

 

 

Series C Preferred Stock

 

On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote. As of March 31, 2024, and December 31, 2023, there were 2,500 shares of Series C Preferred Stock issued and outstanding and the shares are held by Mr. Conway.

 

Series D Preferred Stock

 

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667 shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway’s employment agreement, the Company issued 1,333 shares of Series D Preferred Stock to Mr. Conway. On July 13, 2021, the Company purchased 18,667 shares of the Company’s Series D Preferred Stock held by Chis.

 

On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the “Series D Amendment”). Under the terms of the Series D Amendment, 4,570 shares of the Company’s preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock and multiply that result by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the “Series D SPA”). Pursuant to the terms of Series D SPA, an investor in exchange for $13,200,000 purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236 shares of Series D Preferred Stock. As of March 31, 2024, and December 31, 2023, there were 1,334 shares, respectively, of Series D Preferred Stock issued and outstanding and a warrant to purchase 3,236 shares of Series D Preferred Stock are outstanding as of March 31, 2024, and December 31, 2023.

 

The warrant has a 15- year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows:

 

  i. Up to 162 (one hundred and sixty-two) Warrant Shares, at any time or times on or after five (5) business days from the closing of the Series D SPA (“the Initial Exercise Date”) subject to up to a maximum number of Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company and no later than on or before the 15th year anniversary of the Initial Exercise Date (“the Termination Date”); and
     
  ii. The Remainder of the Warrant representing up to 3,074 (three thousand and seventy-four) Warrant Shares (“Remaining Warrant Shares”) shall be locked up for a period of 36 (thirty-six) months from the Initial Exercise Date (“Lock Up Period”) and shall become exercisable at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date (“Lock Up Period Termination Date”) and no later than on or before the Termination Date, as follows:

 

  a. During every 1 (one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034, and until the Termination Date.

 

 

Series E Preferred Stock

 

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. As of March 31, 2024, and December 31, 2023, there were -0- shares of Series E Preferred Stock issued and outstanding, respectively.

 

v3.24.1.1.u2
NONCONTROLLING INTEREST
3 Months Ended
Mar. 31, 2024
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTEREST

NOTE 12 – NONCONTROLLING INTEREST

 

On August 19, 2021, the Company formed Ozop Capital. The Company initially owned 51% with PJN Holdings, LLC (“PJN”) owning 49%. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the unaudited consolidated financial statements. On September 13, 2022, there was a change in the ownership percentages, as PJN returned 490,000 shares, representing their 49% ownership. As of that date, Ozop Capital is a wholly owned subsidiary of the Company. As of March 31, 2024, and December 31, 2023, the accumulative noncontrolling interest is $784,777.

 

v3.24.1.1.u2
OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES
3 Months Ended
Mar. 31, 2024
Operating Lease Right-of-use Assets And Operating Lease Liabilities  
OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES

NOTE 13 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES

 

On April 14, 2021, the Company entered into a five-year lease which began on June 1, 2021, for approximately 8,100 square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026. Initial lease payments of $13,148 begin on June 1, 2021, and increase by approximately 2.4% annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $702,888 for this lease. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility.

 

In adopting Topic 842, the Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.

 

 

Right-of-use assets are summarized below:

   March 31, 2024   December 31, 2023 
Office and warehouse lease  $702,888   $702,888 
Less: Accumulated amortization   (365,852)   (330,437)
Right-of-use assets, net  $337,036   $372,451 

 

Operating lease liabilities are summarized as follows:

   March 31, 2024   December 31, 2023 
Lease liability  $348,997   $384,382 
Less current portion   (151,800)   (147,993)
Long term portion  $197,197   $236,389 

 

Maturity of lease liabilities are as follows:

   Amount 
For the year ending December 31, 2024 (remaining period)  $129,468 
For the year ending December 31, 2025   175,942 
For the year ended December 31, 2026   74,030 
Total  $379,440 
Less: present value discount   (30,443)
Lease liability  $348,997 

 

The Company recorded $29 and $28,701 operating lease expense (after netting off the sublease income) for the three months ended March 31, 2024, and 2023, respectively.

 

v3.24.1.1.u2
DISCONTINUED OPERATIONS
3 Months Ended
Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS

NOTE 14 – DISCONTINUED OPERATIONS

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023. On October 3, 2022, PCTI filed a Voluntary Petition for Non- Individuals Filing for Bankruptcy. On November 30, 2022, the Trustee filed a Notice of Abandonment of Estate Property, as it is over encumbered by the secured creditors. No objections were filed, and as such the inventory and equipment is now considered abandoned to the secured creditors to do with what they wish. In March 2023, the Trustee declared this a no-asset case and closed the bankruptcy.

 

The results of operations of this component, for all periods, are separately reported as “discontinued operations”. A reconciliation of the major classes of line items constituting the income (loss) from discontinued operations, net of income taxes as is presented in the unaudited Consolidated Statements of Operations for the three months ended March 31, 2024, and 2023, are summarized below:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Revenues  $3,573   $5,363 
Cost of goods sold   -    - 
Gross profit   3,573    5,363 
Operating expenses   -    - 
Interest expense   -    - 
Income from discontinued operations  $3,573   $5,363 

 

 

There are no assets as of March 31, 2024, and December 31, 2023, as the secured lender has taken possession. Liabilities of discontinued operations are separately reported as of March 31, 2024, and December 31, 2023. All liabilities are classified as current. The following tables present the reconciliation of carrying amounts of the major classes of liabilities of the Company classified as discontinued operations in the consolidated balance sheets at March 31, 2024, and December 31, 2023:

 

Current liabilities

 

   March 31,
2024
   December 31,
2023
 
Accounts payable and accrued liabilities  $445,565   $445,565 
Current portion of notes payable   589,246    589,246 
Deferred revenues   -    3,573 
Total current liabilities of discontinued operations  $1,034,811   $1,038,384 

 

On May 16, 2022, Huntington National Bank (“Huntington”) filed a Complaint for Confession of Judgment (“COJ”) against Catherine Chis (“Chis”). Chis was the former CEO of PCTI and a Guarantor on Huntington’s Letter of Credit financing (“LOC”) and a Term Loan (“Term Loan”). The Chis COJ for the LOC was $352,415 and accrues per diem interest of $63.65, and the Chis COJ for the Term Loan was $141,415 and accrues per diem interest of $28.60. On June 24, 2022, Huntington filed a COJ against Power Conversion Technologies, Inc (“PCTI”). The PCTI COJ for the LOC was for $354,774 and accrues per diem interest of $63.65 and the PCTI COJ for the LOC was for $142,473 and accrues per diem interest of $28.60. On July 20, 2022, Huntington assigned the PCTI judgment against PCTI to Meraki Advisors, LLC. (“Meraki”). The Company’s understanding is Meraki is a Pennsylvania limited liability company, controlled by Chis.

 

Included in the Current portion of notes payable are the principal balances of Huntington’s LOC of $344,166 and Term Loan of $134,681. Accrued interest and fees on the LOC and Term Loan debt $54,256 is included in accounts payable and accrued liabilities.

 

v3.24.1.1.u2
INCOME TAXES
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 15 - INCOME TAXES

 

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely- than not that some or all of the deferred tax assets will not be realized.

 

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of March 31, 2024, and December 31, 2023.

 

v3.24.1.1.u2
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16 – SUBSEQUENT EVENTS

 

From April 1, 2024, through the filing of this report, the Company sold to GHS 298,285,992 shares of common stock for proceeds of $187,995 net of offering costs.

 

On April 4, 2024, the Company executed a Settlement Agreement (the “Settlement”) with its former employees (see Note 10) and Your Home Solutions Corp (“YHS”). YHS and the former employees were all defendants (the “Defendants”) in the Complaint. Pursuant to the terms of the Settlement, the Defendants are to pay the Company $500,000 within 2 days of the Settlement and $625,000 on or before sixty (60) days from the Settlement. In exchange, the Company agreed to release all Defendants from the lawsuit upon the final and full payment of $1,125,000 and to deliver 11 containers of solar panels. As of May 2, 2024, the Company has received the $1,125,000, and the Company has released the 11 containers by May 6, 2024.

 

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on April 16, 2024.

 

The unaudited consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries Ozop Capital Partners, Inc., Ozop Engineering and Design, Inc., Power Conversion Technologies, Inc. (“PCTI”), Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”).

 

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2024, and December 31, 2023.

 

Sales Concentration and credit risk

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2024, and 2023, and their accounts receivable balance as of March 31, 2024:

 

   Sales % Three Months Ended March 31, 2024   Sales % Three Months Ended March 31, 2023   Accounts receivable balance March 31, 2024 
Customer A   67%   -   $39,800 
Customer B   10%   -   $39,679 
Customer C   -    97%  $- 

 

Accounts Receivable

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventory

Inventory

 

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs consist of finished goods. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Finished goods inventories as of March 31, 2024, and December 31, 2023, were $1,027,298 and $1,089,979, respectively. Based on current market conditions related to solar panels including but not limited to reduced selling prices in the industry and the abundance of inventory supply in the market, management determined that the net realizable value of certain of the Company’s inventory required a lower of cost or market adjustment of $1,495,978 to the historical cost of inventory purchases for the year ended December 31, 2023. There are no inventory markdowns for the three months ended March 31, 2024, and 2023.

 

Purchase concentration

Purchase concentration

 

OES purchases finished renewable energy products from its suppliers. For the three months ended March 31, 2023, there was one supplier that accounted for 100%. For the three months ended March 31, 2024, the Company made no purchases.

 

 

Property, plant, and equipment

Property, plant, and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

  Building 10-25 years
  Office furniture and equipment 3-5 years
  Warehouse equipment 7 years

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products or providing services by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms for product sales or upon delivery of service to the customer for installation services. Any advance payments are recorded as current liability until revenue is recognized.

 

For product sales contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges.

 

For installation services contracts with customers, the Company invoices the customer upon completion of the job and recognizes revenue based on the invoiced amount.

 

The following table disaggregates our revenue by major source for the three months ended March 31, 2024, and 2023:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Sourced and distributed products  $75,222   $2,758,798 
OED Installations   176,500    32,400 
Total  $251,722   $2,791,198 

 

Revenues from sourced and distributed products were previously purchased from suppliers as finished goods and were either in the Carlsbad warehouse or in a third-party warehouse.

 

Advertising and Marketing Expenses

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2024, and 2023, the Company recorded advertising and marketing expenses of $15,671 and $17,772, respectively.

 

Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Discontinued Operations

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

 

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2024, and 2023. For additional information, see Note 14- Discontinued Operations.

 

Distinguishing Liabilities from Equity

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity, or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in the fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses and certain notes payable, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2024, and December 31, 2023, for each fair value hierarchy level:

 

March 31, 2024  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $754,073   $754,073 

 

December 31, 2023  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $1,216,078   $1,216,078 

 

 

Leases

Leases

 

The Company accounts for leases under ASU 2016-02 (see Note 13), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

 

Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the unaudited consolidated statements of operations.

 

Income Taxes

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

 

Segment Policy

Segment Policy

 

The Company has no reportable segments as it operates in one segment: renewable energy.

 

Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2024, and 2023, the Company’s dilutive securities are convertible into approximately 10,280,235,000 and 8,471,310,904 shares of common stock respectively. The following table represents the classes of dilutive securities as of March 31, 2024, and 2023:

 

   March 31, 2024   March 31, 2023 
Convertible preferred stock (1)   8,732,725,692    7,318,548,198 
Unexercised common stock purchase warrants (1)   807,024,518    1,047,024,518 
Convertible notes payable (1)   72,738,215    11,025,635 
Promissory notes payable (1)   667,746,575    94,712,553 
Total   10,280,235,000    8,471,310,904 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.

 

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows.

 

Other than the above, there have been no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2024, that are of significance or potential significance to the Company.

v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2024, and 2023, and their accounts receivable balance as of March 31, 2024:

 

   Sales % Three Months Ended March 31, 2024   Sales % Three Months Ended March 31, 2023   Accounts receivable balance March 31, 2024 
Customer A   67%   -   $39,800 
Customer B   10%   -   $39,679 
Customer C   -    97%  $- 
SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS

 

  Building 10-25 years
  Office furniture and equipment 3-5 years
  Warehouse equipment 7 years
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates our revenue by major source for the three months ended March 31, 2024, and 2023:

 

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Sourced and distributed products  $75,222   $2,758,798 
OED Installations   176,500    32,400 
Total  $251,722   $2,791,198 
SCHEDULE OF DERIVATIVE INSTRUMENTS

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2024, and December 31, 2023, for each fair value hierarchy level:

 

March 31, 2024  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $754,073   $754,073 

 

December 31, 2023  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $1,216,078   $1,216,078 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

   March 31, 2024   March 31, 2023 
Convertible preferred stock (1)   8,732,725,692    7,318,548,198 
Unexercised common stock purchase warrants (1)   807,024,518    1,047,024,518 
Convertible notes payable (1)   72,738,215    11,025,635 
Promissory notes payable (1)   667,746,575    94,712,553 
Total   10,280,235,000    8,471,310,904 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.
v3.24.1.1.u2
PROPERTY AND EQUIPMENT (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

The following table summarizes the Company’s property and equipment:

 

   March 31, 2024   December 31, 2023 
Office equipment  $224,733   $224,733 
Building and building improvements   600,000    600,000 
           
Less: Accumulated Depreciation   (223,290)   (205,834)
Property and Equipment, Net  $601,443   $618,899 
v3.24.1.1.u2
DERIVATIVE LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Liabilities  
SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE

A summary of the activity related to derivative liabilities for the three months ended March 31, 2024, is as follows:

 

   Derivative liabilities associated with warrants   Derivative liabilities associated with convertible notes   Total derivative liabilities 
             
Balance January 1, 2024  $1,187,076   $29,002   $1,216,078 
Change in fair value   (465,157)   3,152    (462,005)
Balance March 31, 2024  $721,919   $32,154   $754,073 
v3.24.1.1.u2
NOTES PAYABLE (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
SCHEDULE OF NOTES PAYABLE

The Company has the following notes payable outstanding:

 

   March 31, 2024   December 31, 2023 
         
Note payable, interest at 8%, matured January 5, 2020, in default  $45,000   $45,000 
Other, due on demand, interest at 6%, currently in default   50,000    50,000 
Note payable $750,000 face value, interest at 12%, matured August 24, 2021, in default   375,000    375,000 
Note payable $389,423 face value, interest at 15%, matures November 6, 2025, net of discount of $90,980 (2024) and $105,220 (2023)   298,443    284,203 
Note payable $1,000,000 face value, interest at 12%, matured November 13, 2021, in default   1,000,000    1,000,000 
Note payable $2,200,000 face value, interest at 15%, matures October 31, 2024, net of discount of $99,167 (2024) and $141,667 (2023)   2,100,833    2,058,333 
Note payable $11,110,000 face value, interest at 15%, matures October 31, 2024, net of discount of $495,833 (2024) and $708,333 (2023)   10,614,167    10,401,667 
Note payable $3,300,000 face value, interest at 15%, matures October 31, 2024, net of discount of $148,750 (2024) and $212,500 (2023)   3,151,250    3,087,500 
Note payable $3,020,000 face value, matured March 31, 2023, in default   1,820,000    1,820,000 
Sub- total notes payable, net of discount   19,454,693    19,121,703 
Less long-term portion, net of discount   298,443    284,203 
Current portion of notes payable, net of discount  $19,156,250   $18,837,500 
v3.24.1.1.u2
OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2024
Operating Lease Right-of-use Assets And Operating Lease Liabilities  
SCHEDULE OF RIGHT-OF-USE ASSETS

Right-of-use assets are summarized below:

   March 31, 2024   December 31, 2023 
Office and warehouse lease  $702,888   $702,888 
Less: Accumulated amortization   (365,852)   (330,437)
Right-of-use assets, net  $337,036   $372,451 
SCHEDULE OF OPERATING LEASE LIABILITIES

Operating lease liabilities are summarized as follows:

   March 31, 2024   December 31, 2023 
Lease liability  $348,997   $384,382 
Less current portion   (151,800)   (147,993)
Long term portion  $197,197   $236,389 
SCHEDULE OF MATURITY OF LEASE LIABILITIES

Maturity of lease liabilities are as follows:

   Amount 
For the year ending December 31, 2024 (remaining period)  $129,468 
For the year ending December 31, 2025   175,942 
For the year ended December 31, 2026   74,030 
Total  $379,440 
Less: present value discount   (30,443)
Lease liability  $348,997 
v3.24.1.1.u2
DISCONTINUED OPERATIONS (Tables)
3 Months Ended
Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF LOSS FROM DISCONTINUED OPERATIONS

   2024   2023 
   Three months ended March 31, 
   2024   2023 
Revenues  $3,573   $5,363 
Cost of goods sold   -    - 
Gross profit   3,573    5,363 
Operating expenses   -    - 
Interest expense   -    - 
Income from discontinued operations  $3,573   $5,363 

 

 

There are no assets as of March 31, 2024, and December 31, 2023, as the secured lender has taken possession. Liabilities of discontinued operations are separately reported as of March 31, 2024, and December 31, 2023. All liabilities are classified as current. The following tables present the reconciliation of carrying amounts of the major classes of liabilities of the Company classified as discontinued operations in the consolidated balance sheets at March 31, 2024, and December 31, 2023:

 

Current liabilities

 

   March 31,
2024
   December 31,
2023
 
Accounts payable and accrued liabilities  $445,565   $445,565 
Current portion of notes payable   589,246    589,246 
Deferred revenues   -    3,573 
Total current liabilities of discontinued operations  $1,034,811   $1,038,384 
v3.24.1.1.u2
ORGANIZATION (Details Narrative) - shares
Mar. 31, 2024
Dec. 31, 2023
May 05, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Capital stock, shares authorized     7,000,000,000
Common stock, shares authorized 6,990,000,000 6,990,000,000 6,990,000,000
Preferred stock, shares authorized 10,000,000 10,000,000 10,000,000
v3.24.1.1.u2
GOING CONCERN AND MANAGEMENT’S PLANS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 01, 2024
Mar. 14, 2024
Feb. 28, 2024
Feb. 12, 2024
Jan. 25, 2024
Jan. 08, 2024
May 02, 2023
May 15, 2024
Apr. 26, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Apr. 30, 2021
Apr. 14, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Retained earnings accumulated deficit                   $ 220,094,275   $ 218,670,480    
Working capital deficit                   28,047,674        
Derivative liabilities current                   754,073   1,216,078    
Debt instrument default amount                   3,315,000        
Shares issued value                   350,555 $ 526,393      
Proceeds from sale of common stock, net of costs                   350,555 526,393 48,000    
Lease term                         5 years 5 years
Common Stock [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Shares issued value                   $ 340,304 $ 107,757      
Number of shares issued                   340,303,728 107,756,783      
Sale of common stock                   146,517,693        
Proceeds from sale of common stock, net of costs                   $ 350,555 $ 526,393      
Common Stock [Member] | GHS Investments LLC [Member] | Subsequent Event [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Shares issued value $ 187,995                          
Number of shares issued 298,285,992                          
Financing And Registration Rights Agreement [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Debt fund issued             $ 10,000,000              
Equity financing agreement description             The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed two hundred fifty percent (250%) of the average of the daily trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company’s common stock to GHS that would result in GHS’s beneficial ownership equaling more than 4.99% of the Company’s outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company’s common stock for the ten (10) consecutive trading days preceding the date on which the applicable put is delivered to GHS. No put will be made in an amount equaling less than $10,000 or greater than $750,000. Puts may be delivered by the Company to GHS until the earlier of twenty-four (24) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares.              
Shares issued value             $ 10,000,000     $ 178,438   $ 1,230,043    
Number of shares issued                   193,786,035   587,432,649    
Financing And Registration Rights Agreement [Member] | Common Stock [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Sale of common stock   70,938,750 62,124,323 60,722,962 61,383,661 85,134,032                
Proceeds from sale of common stock, net of costs   $ 60,152 $ 57,422 $ 60,864 $ 66,350 $ 105,767       $ 172,117        
Financing And Registration Rights Agreement [Member] | Common Stock [Member] | Subsequent Event [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Number of shares issued               298,285,992            
Proceeds from sale of common stock, net of costs               $ 187,995            
1st GHS Purchase Agreement [Member] | Common Stock [Member] | GHS Investments LLC [Member]                            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                            
Number of shares issued                 1,000,000,000          
v3.24.1.1.u2
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR (Details) - Customer Concentration Risk [Member] - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Customer A [Member] | Revenue Benchmark [Member]    
Product Information [Line Items]    
Sales concentration and credit risk 67.00%
Customer A [Member] | Accounts Receivable [Member]    
Product Information [Line Items]    
Accounts receivable $ 39,800  
Customer B [Member] | Revenue Benchmark [Member]    
Product Information [Line Items]    
Sales concentration and credit risk 10.00%
Customer B [Member] | Accounts Receivable [Member]    
Product Information [Line Items]    
Accounts receivable $ 39,679  
Customer C [Member] | Revenue Benchmark [Member]    
Product Information [Line Items]    
Sales concentration and credit risk 97.00%
Customer C [Member] | Accounts Receivable [Member]    
Product Information [Line Items]    
Accounts receivable  
v3.24.1.1.u2
SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS (Details)
Mar. 31, 2024
Warehouse Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 7 years
Minimum [Member] | Building and Building Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 10 years
Minimum [Member] | Office Furniture And Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Maximum [Member] | Building and Building Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 25 years
Maximum [Member] | Office Furniture And Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
v3.24.1.1.u2
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Product Information [Line Items]    
Total $ 251,722 $ 2,791,198
Sourced And Distributed Products [Member]    
Product Information [Line Items]    
Total 75,222 2,758,798
O E D Installations [Member]    
Product Information [Line Items]    
Total $ 176,500 $ 32,400
v3.24.1.1.u2
SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Fair Value, Inputs, Level 1 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Derivative Liabilities
Total
Fair Value, Inputs, Level 2 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Derivative Liabilities
Total
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Derivative Liabilities 754,073 1,216,078
Total $ 754,073 $ 1,216,078
v3.24.1.1.u2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 10,280,235,000 8,471,310,904
Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total [1] 8,732,725,692 7,318,548,198
Unexercised Common Stock Purchase Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total [1] 807,024,518 1,047,024,518
Convertible Notes Payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total [1] 72,738,215 11,025,635
Promissory Note Payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total [1] 667,746,575 94,712,553
[1] The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.
v3.24.1.1.u2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) (Parenthetical)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Outstanding shares, percentage 4.99%
v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Product Information [Line Items]      
Inventory finished goods $ 1,027,298   $ 1,089,979
Market adjustment     $ 1,495,978
Advertising and marketing expenses $ 15,671 $ 17,772  
Incremental borrowing percentage 7.50%    
Dilutive securities common stock, shares 10,280,235,000 8,471,310,904  
Accounts Payable [Member] | Supplier Concentration Risk [Member] | One Supplier [Member]      
Product Information [Line Items]      
Concentration of credit risk   100.00%  
v3.24.1.1.u2
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Less: Accumulated Depreciation $ (223,290) $ (205,834)
Property and Equipment, Net 601,443 618,899
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Building and building improvements 224,733 224,733
Building and Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Building and building improvements $ 600,000 $ 600,000
v3.24.1.1.u2
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Property, Plant and Equipment [Abstract]    
Depreciation expenses $ 17,456 $ 23,022
v3.24.1.1.u2
CONVERTIBLE NOTES PAYABLE (Details Narrative) - 15% Convertible Note [Member] - USD ($)
Jun. 10, 2020
Mar. 31, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]      
Debt interest rate 15.00%    
Convertible notes outstanding balance   $ 25,000 $ 25,000
v3.24.1.1.u2
SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Derivative liability, beginning balance $ 1,216,078
Change in fair value (462,005)
Derivative liability, ending balance 754,073
Derivative Liabilities Associated With Warrants [Member]  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Derivative liability, beginning balance 1,187,076
Change in fair value (465,157)
Derivative liability, ending balance 721,919
Derivative Liabilities Associated With Convertible Notes [Member]  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Derivative liability, beginning balance 29,002
Change in fair value 3,152
Derivative liability, ending balance $ 32,154
v3.24.1.1.u2
DERIVATIVE LIABILITIES (Details Narrative)
Mar. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liabilities | $ $ 754,073 $ 1,216,078
Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected volatility 5.38 5.26
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 4.48 4.3
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 5.38 5.26
Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected volatility 88 48
Measurement Input Price Volatility One [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 85 48
Measurement Input Price Volatility One [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 115 99
Measurement Input, Exercise Price [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 0.0019  
Measurement Input, Exercise Price [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrant measurement input 0.15  
v3.24.1.1.u2
SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount $ 19,454,693 $ 19,121,703
Less long-term portion, net of discount 298,443 284,203
Current portion of notes payable, net of discount 19,156,250 18,837,500
Note Payable [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 45,000 45,000
Other [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 50,000 50,000
Note Payable One [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 375,000 375,000
Note Payable Two [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 298,443 284,203
Note Payable Three [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 1,000,000 1,000,000
Note Payable Four [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 2,100,833 2,058,333
Note Payable Five [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 10,614,167 10,401,667
Note Payable Six [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount 3,151,250 3,087,500
Note Payable Seven [Member]    
Short-Term Debt [Line Items]    
Sub- total notes payable, net of discount $ 1,820,000 $ 1,820,000
v3.24.1.1.u2
SCHEDULE OF NOTES PAYABLE (Details) (Parenthetical) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Note Payable [Member]    
Short-Term Debt [Line Items]    
Interest rate 8.00% 8.00%
Maturity date Jan. 05, 2020 Jan. 05, 2020
Other [Member]    
Short-Term Debt [Line Items]    
Interest rate 6.00% 6.00%
Note Payable One [Member]    
Short-Term Debt [Line Items]    
Interest rate 12.00% 12.00%
Maturity date Aug. 24, 2021 Aug. 24, 2021
Face value $ 750,000 $ 750,000
Note Payable Two [Member]    
Short-Term Debt [Line Items]    
Interest rate 15.00% 15.00%
Maturity date Nov. 06, 2025 Nov. 06, 2025
Face value $ 389,423 $ 389,423
Discount amount $ 90,980 $ 105,220
Note Payable Three [Member]    
Short-Term Debt [Line Items]    
Interest rate 12.00% 12.00%
Maturity date Nov. 13, 2021 Nov. 13, 2021
Face value $ 1,000,000 $ 1,000,000
Note Payable Four [Member]    
Short-Term Debt [Line Items]    
Interest rate 15.00% 15.00%
Maturity date Oct. 31, 2024 Oct. 31, 2024
Face value $ 2,200,000 $ 2,200,000
Discount amount $ 99,167 $ 141,667
Note Payable Five [Member]    
Short-Term Debt [Line Items]    
Interest rate 15.00% 15.00%
Maturity date Oct. 31, 2024 Oct. 31, 2024
Face value $ 11,110,000 $ 11,110,000
Discount amount $ 495,833 $ 708,333
Note Payable Six [Member]    
Short-Term Debt [Line Items]    
Interest rate 15.00% 15.00%
Maturity date Oct. 31, 2024 Oct. 31, 2024
Face value $ 3,300,000 $ 3,300,000
Discount amount $ 148,750 $ 212,500
Note Payable Seven [Member]    
Short-Term Debt [Line Items]    
Maturity date Mar. 31, 2023 Mar. 31, 2023
Face value $ 3,020,000 $ 3,020,000
v3.24.1.1.u2
NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Nov. 06, 2023
Nov. 11, 2022
Oct. 31, 2022
Dec. 13, 2021
Dec. 07, 2021
Mar. 23, 2021
Mar. 17, 2021
Feb. 16, 2021
Feb. 09, 2021
Nov. 20, 2020
Nov. 13, 2020
Nov. 06, 2020
Aug. 25, 2020
Aug. 24, 2020
Jun. 23, 2020
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Short-Term Debt [Line Items]                                      
Accounts and accrued expenses                               $ 8,822,759   $ 8,026,784  
Principal balance outstanding amount                               19,454,693   19,121,703  
Interest expense                               $ 1,056,887 $ 1,221,533    
Warrants and Rights Outstanding, Term                               15 years      
Holder [Member]                                      
Short-Term Debt [Line Items]                                      
Number of warrants to purchase                     125,000,000                
Warrant exercise price                     $ 0.008                
Stock issued during period, shares                     2     2          
Warrants and Rights Outstanding, Term                     5 years 5 years              
Promissory Note [Member]                                      
Short-Term Debt [Line Items]                                      
Principal balance outstanding amount                               $ 375,000   375,000  
Description of default note                               This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law.      
Interest Payable                               $ 292,747   270,247  
Promissory Note [Member] | Lender [Member]                                      
Short-Term Debt [Line Items]                                      
Debt instrument, face amount           $ 11,110,000 $ 11,110,000                        
Debt instrument, maturity date             Mar. 17, 2022                        
Debt Instrument, unamortized discount           1,000,000                   495,833   708,333  
Proceeds from notes payable           10,000,000                          
Principal balance outstanding amount                               11,110,000   11,110,000  
Debt instrument, interest rate, stated percentage     15.00%       12.00%                        
Number of warrants to purchase     250,000,000                                
Warrant exercise price     $ 0.0067                                
Debt Instrument, carrying amount                               10,614,167   10,401,667  
Lender costs           $ 110,000                          
Warrant expiry date     Oct. 31, 2025                                
Promissory Note [Member] | Lender [Member] | March 31 2023 [Member]                                      
Short-Term Debt [Line Items]                                      
Debt instrument, face amount   $ 3,020,000                                  
Debt instrument, maturity date   Mar. 31, 2023                                  
Debt Instrument, unamortized discount   $ 250,000                             250,000 950,000 $ 250,000
Accounts and accrued expenses   260,000                                  
Proceeds from notes payable   $ 2,510,000                                  
Original issue discount, amortized                                 181,818    
Repayments of debt                               1,200,000 550,000    
Principal balance outstanding amount                               1,820,000   1,820,000  
Promissory Note [Member] | Lender [Member] | December 7, 2022 [Member]                                      
Short-Term Debt [Line Items]                                      
Debt instrument, face amount         $ 3,300,000                            
Debt instrument, maturity date         Dec. 07, 2022                            
Debt Instrument, unamortized discount         $ 300,000                     148,750   212,500  
Proceeds from notes payable       $ 3,000,000                              
Principal balance outstanding amount                               3,300,000   3,300,000  
Debt instrument, interest rate, stated percentage     15.00%   12.00%                            
Number of warrants to purchase     75,000,000                                
Warrant exercise price     $ 0.0067                                
Value of warrants     $ 510,000                                
Interest expense                               63,750 63,750    
Debt Instrument, carrying amount                               3,151,250   3,087,500  
Promissory Note [Member] | Lender [Member] | March 17 2022 [Member]                                      
Short-Term Debt [Line Items]                                      
Value of warrants     1,700,000                                
Interest expense                               212,500   212,500  
Promissory Note [Member] | Lender [Member] | February 9 2021 [Member]                                      
Short-Term Debt [Line Items]                                      
Value of warrants     $ 340,000                                
Interest expense                               42,500 $ 42,500    
Promissory Note [Member] | Holder [Member]                                      
Short-Term Debt [Line Items]                                      
Debt instrument, face amount                     $ 1,000,000 $ 389,423   $ 750,000 $ 210,000        
Debt instrument, maturity date Nov. 06, 2025                   Nov. 13, 2021 Nov. 06, 2023   Aug. 24, 2021          
Debt Instrument, unamortized discount                               90,980   105,220  
Proceeds from notes payable                   $ 890,000     $ 663,000            
Principal balance outstanding amount                       $ 120,000       389,423   389,423  
Debt instrument, interest rate, stated percentage 15.00%                   12.00% 12.00%   12.00%          
Number of warrants to purchase 60,000,000                     60,000,000   122,950,819          
Warrant exercise price $ 0.0019                     $ 0.0075   $ 0.0061          
Value of warrants $ 113,921                                    
Interest expense                               14,240      
Debt Instrument, carrying amount                               $ 298,443   284,203  
Debt instrument, description                     Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date.     Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date.          
Legal fees                   $ 110,000     $ 87,000            
Description of default note                               This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law.      
Interest Payable                               $ 675,452   615,452  
Debt instrument, increase, accrued interest                       $ 8,716     $ 15,707        
Promissory Note One [Member] | Lender [Member]                                      
Short-Term Debt [Line Items]                                      
Debt instrument, face amount               $ 2,200,000 $ 2,200,000                    
Debt instrument, maturity date                 Feb. 09, 2022                    
Debt Instrument, unamortized discount               200,000                      
Proceeds from notes payable               $ 2,000,000                      
Debt instrument, interest rate, stated percentage                 12.00%                    
Promissory Note One [Member] | Holder [Member]                                      
Short-Term Debt [Line Items]                                      
Principal balance outstanding amount                               1,000,000   1,000,000  
Promissory Note Two [Member] | Lender [Member]                                      
Short-Term Debt [Line Items]                                      
Debt Instrument, unamortized discount                               99,167   141,667  
Principal balance outstanding amount                               2,200,000   2,200,000  
Debt instrument, interest rate, stated percentage     15.00%                                
Number of warrants to purchase     50,000,000                                
Warrant exercise price     $ 0.0067                                
Debt Instrument, carrying amount                               $ 2,100,833   $ 2,058,333  
v3.24.1.1.u2
DEFERRED LIABILITY (Details Narrative) - USD ($)
Nov. 11, 2022
Feb. 26, 2021
Sep. 02, 2020
Mar. 31, 2024
Dec. 31, 2023
Deferred liability       $ 490,855 $ 490,495
Decrease in deferred liability $ 260,000        
Promissory Note [Member]          
Decrease in deferred liability $ 260,000        
Vehicle Service Contracts [Member]          
Deferred liability       $ 855 $ 495
Power Conversion Technologies Inc [Member] | Exchange Agreement [Member]          
Deferred liability     $ 750,000    
Product liability contingency, third-Party recovery, percentage     3.00%    
Number of shares exchanged   175,000,000      
Royalty percentage   1.80%      
v3.24.1.1.u2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jan. 01, 2022
Jul. 10, 2020
Jan. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Related Party Transaction [Line Items]          
General and administrative related parties       $ 240,000 $ 240,000
Mr Conway [Member] | Employment Agreement [Member]          
Related Party Transaction [Line Items]          
Compensation value   $ 20,000 $ 20,000    
Amount of initial annual compensation $ 240,000        
General and administrative related parties       $ 240,000 $ 240,000
v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
May 02, 2024
Apr. 04, 2024
Sep. 01, 2021
Feb. 26, 2021
Sep. 02, 2020
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Mar. 04, 2019
Loss Contingencies [Line Items]                  
Issuance of common stock shares           637,755   637,755  
Issuance of common stock           $ 350,555 $ 526,393 $ 48,000  
Accounts Payable and Accrued Liabilities [Member]                  
Loss Contingencies [Line Items]                  
Amount due as per agreement           243,272   243,272  
RMA Agreement [Member]                  
Loss Contingencies [Line Items]                  
Reduced fee     $ 100,000         48,000  
Agreed amount to pay for the services     50,000            
Number of restricted stock issued, value     $ 50,000            
Seperation Agreement [Member] | Salman J. Chaudhry [Member] | Related Party [Member]                  
Loss Contingencies [Line Items]                  
Due to officers or stockholders, current           $ 162,085   $ 162,085 $ 227,200
Agreement With Third Party [Member] | P C T I [Member]                  
Loss Contingencies [Line Items]                  
Professional fees         $ 750,000        
Collaborative arrangement, rights and obligations         PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement.        
Amended Agreement With Third Party [Member] | P C T I [Member]                  
Loss Contingencies [Line Items]                  
Number of common stock exchanged       175,000,000          
Royalty percentage       1.80%          
Settlement Agreement [Member] | Subsequent Event [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency accrual payments $ 1,125,000 $ 1,125,000              
Settlement Agreement [Member] | WIthin Two Days [Member] | Subsequent Event [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency accrual payments   500,000              
Settlement Agreement [Member] | Before Sixty Days [Member] | Subsequent Event [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency accrual payments   $ 625,000              
v3.24.1.1.u2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 14, 2024
Feb. 28, 2024
Feb. 12, 2024
Jan. 25, 2024
Jan. 08, 2024
Jul. 28, 2021
Jul. 13, 2021
Aug. 28, 2020
Jul. 10, 2020
Jul. 07, 2020
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
May 05, 2023
Jul. 27, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of common stock                     $ 350,555 $ 526,393 $ 48,000    
Stock issuance cost                     $ 12,384 $ 19,110      
Common stock shares authorized                     6,990,000,000   6,990,000,000 6,990,000,000  
Common stock, par value                     $ 0.001   $ 0.001    
Common stock, shares issued                     5,821,817,128   5,481,513,400    
Common stock, shares outstanding                     5,821,817,128   5,481,513,400    
Preferred stock, shares authorized                     10,000,000   10,000,000 10,000,000  
Preferred stock, par value                     $ 0.001   $ 0.001    
Warrant term                     15 years        
Warrant [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Warrant exercise                     162        
Warrant exercise, description                     During every 1 (one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034, and until the Termination Date.        
Remaining Warrant Shares [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Lock up of warrants                     3,074        
Lock up period of warrants                     36 months        
Series C Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                     50,000   50,000    
Preferred stock, par value                     $ 0.001   $ 0.001    
Preferred stock shares issued                     2,500   2,500    
Preferred stock shares outstanding                     2,500   2,500    
Series D Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                     4,570   4,570    
Preferred stock, par value                     $ 0.001   $ 0.001    
Preferred stock shares issued                     1,334   1,334    
Preferred stock shares outstanding                     1,334   1,334    
Purchase of warrants                     3,236   3,236    
Series D Preferred Stock [Member] | Mr Conway [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of shares of common stock sold, net of issuance costs, shares               1,333              
Series D Preferred Stock [Member] | Chis [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of purchased shares             18,667                
Series E Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                     3,000   3,000    
Preferred stock, par value                     $ 0.001   $ 0.001    
Preferred stock shares issued                     0   0    
Preferred stock shares outstanding                     0   0    
Financing And Registration Rights Agreement [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of shares of common stock sold, net of issuance costs, shares                     193,786,035   587,432,649    
Amendment Certificates Of Designation [Member] | Series C Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                   50,000          
Preferred stock, voting rights                   The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.          
Securities Purchase Agreement [Member] | Series D Preferred Stock [Member] | P C T I [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of shares of common stock sold, net of issuance costs, shares                 18,667            
Series D Amendment [Member] | Series D Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                             4,570
Series DSPA [Member] | Series D Preferred Stock [Member] | Investor [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Proceeds from issuance of preferred stock and preference stock           $ 13,200,000                  
Purchase of warrants           3,236                  
Certificates of Designation [Member] | Series E Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Preferred stock, shares authorized                   3,000          
Preferred stock, redemption amount                   $ 1,000          
Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of shares of common stock sold, net of issuance costs, shares                     340,303,728 107,756,783      
Issuance of common stock                     $ 350,555 $ 526,393      
Stock issuance cost                     $ 12,384 $ 19,110      
Sold shares during transaction                     146,517,693        
Common Stock [Member] | Financing And Registration Rights Agreement [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Issuance of common stock $ 60,152 $ 57,422 $ 60,864 $ 66,350 $ 105,767           $ 172,117        
Sold shares during transaction 70,938,750 62,124,323 60,722,962 61,383,661 85,134,032                    
Sold shares during transaction per share $ 0.00088 $ 0.00096 $ 0.00104 $ 0.00112 $ 0.00128                    
Broker fees $ 2,274 $ 2,218 $ 2,288 $ 2,400 $ 3,204                    
v3.24.1.1.u2
NONCONTROLLING INTEREST (Details Narrative) - USD ($)
Sep. 13, 2022
Mar. 31, 2024
Dec. 31, 2023
Aug. 19, 2021
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Accumulative noncontrolling interest   $ 784,777 $ 784,777  
Brian Conway [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Noncontrolling interest percentage       51.00%
PJN Strategies [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Noncontrolling interest percentage 49.00%     49.00%
Number of share returned 490,000      
v3.24.1.1.u2
SCHEDULE OF RIGHT-OF-USE ASSETS (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Operating Lease Right-of-use Assets And Operating Lease Liabilities    
Office and warehouse lease $ 702,888 $ 702,888
Less: Accumulated amortization (365,852) (330,437)
Right-of-use assets, net $ 337,036 $ 372,451
v3.24.1.1.u2
SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Operating Lease Right-of-use Assets And Operating Lease Liabilities    
Lease liability $ 348,997 $ 384,382
Less current portion (151,800) (147,993)
Long term portion $ 197,197 $ 236,389
v3.24.1.1.u2
SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Operating Lease Right-of-use Assets And Operating Lease Liabilities    
For the year ending December 31, 2024 (remaining period) $ 129,468  
For the year ending December 31, 2025 175,942  
For the year ended December 31, 2026 74,030  
Total 379,440  
Less: present value discount (30,443)  
Lease liability $ 348,997 $ 384,382
v3.24.1.1.u2
OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES (Details Narrative)
3 Months Ended
Jun. 01, 2021
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2021
USD ($)
Apr. 30, 2021
Apr. 14, 2021
ft²
Operating lease term           5 years 5 years
Area of land | ft²             8,100
Lease payments increase percentage 2.40%            
Right of use asset   $ 337,036   $ 372,451      
Operating lease liability   348,997   $ 384,382      
Operating lease expense   $ 29 $ 28,701        
Accounting Standards Update 2016-02 [Member]              
Right of use asset         $ 702,888    
Operating lease liability         $ 702,888    
CALIFORNIA              
Initial lease payments $ 13,148            
Estimated incremental borrowing rate             7.50%
v3.24.1.1.u2
SCHEDULE OF LOSS FROM DISCONTINUED OPERATIONS (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]      
Revenues $ 3,573 $ 5,363  
Cost of goods sold  
Gross profit 3,573 5,363  
Operating expenses  
Interest expense  
Income from discontinued operations 3,573 $ 5,363  
Accounts payable and accrued liabilities 445,565   $ 445,565
Current portion of notes payable 589,246   589,246
Deferred revenues   3,573
Total current liabilities of discontinued operations $ 1,034,811   $ 1,038,384
v3.24.1.1.u2
DISCONTINUED OPERATIONS (Details Narrative) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Jun. 24, 2022
May 16, 2022
Total assets of discontinued operations $ 0 $ 0    
Letter of credit 344,166      
Term loan 134,681      
Accounts Payable and Accrued Liabilities [Member]        
Accrued interest and fees $ 54,256      
Catherine Chis [Member]        
Accrues per interest       $ 28.60
Line of credit       $ 141,415
Catherine Chis [Member] | Letter of Credit [Member]        
Face value of LOC       $ 352,415
Accrues per interest       $ 63.65
Power Conversion Technologies Inc [Member]        
Accrues per interest     $ 28.60  
Line of credit     $ 142,473  
Power Conversion Technologies Inc [Member] | Letter of Credit [Member]        
Face value of LOC     $ 354,774  
Accrues per interest     $ 63.65  
v3.24.1.1.u2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
3 Months Ended
May 02, 2024
Apr. 04, 2024
Apr. 01, 2024
Mar. 31, 2024
Mar. 31, 2023
Subsequent Event [Line Items]          
Stock issued during the period       $ 350,555 $ 526,393
Common Stock [Member]          
Subsequent Event [Line Items]          
Issuance of shares of common stock sold, net of issuance costs, shares       340,303,728 107,756,783
Stock issued during the period       $ 340,304 $ 107,757
Subsequent Event [Member] | Settlement Agreement [Member]          
Subsequent Event [Line Items]          
Loss contingency accrual payments $ 1,125,000 $ 1,125,000      
GHS Investments LLC [Member] | Subsequent Event [Member] | Common Stock [Member]          
Subsequent Event [Line Items]          
Issuance of shares of common stock sold, net of issuance costs, shares     298,285,992    
Stock issued during the period     $ 187,995    
WIthin Two Days [Member] | Subsequent Event [Member] | Settlement Agreement [Member]          
Subsequent Event [Line Items]          
Loss contingency accrual payments   500,000      
Before Sixty Days [Member] | Subsequent Event [Member] | Settlement Agreement [Member]          
Subsequent Event [Line Items]          
Loss contingency accrual payments   $ 625,000      

Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Ozop Energy Solutions (PK) Charts.
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Ozop Energy Solutions (PK) Charts.